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ABSTRACT 
 
 
Post-weaning diarrhea (PWD) in pigs is caused by enterotoxigenic Escherichia coli (ETEC) 
which is often controlled by antibiotic feed supplements with the potential risk of generation of 
antibiotic resistant bacteria. Prevention of attachment of F4ac positive ETEC to intestinal 
mucosa may potentially be used as one of the antibiotic-free strategies for the control of this 
disease. F4ac-positive ETEC has been reported to bind to fat globule membranes in porcine milk.  
In this study, we used an affinity chromatography technique to identify individual milk fat 
globule membrane (MFGM) proteins that bind to F4ac fimbriae.  An affinity column with 
covalently coupled F4ac fimbriae to activated Sepharose was created and the following F4ac-
binding proteins were isolated from the porcine MFGM: lactadherin, butyrophilin, adipophilin, 
acyl-CoA synthetase 3, fatty acid binding protein 3, and xanthine dehydrogenase. 
Selected individual proteins of porcine MFGM, namely: xanthine dehydrogenase, 
butyrophilin, lactadherin, and fatty acid binding protein were isolated and tested for their 
inhibitory effects against attachment of F4ac positive ETEC and of F4ac fimbriae to either a 
small intestinal cell line (IPEC-J2) or primary porcine enterocytes by competitive ELISA. All of 
these proteins, except xanthine dehydrogenase, decreased attachment of F4ac positive E. coli and 
F4ac fimbriae to the intestinal cell line or primary enterocytes in a dose-dependent manner. 
Lactadherin demonstrated the strongest inhibitory effect on F4ac positive E. coli adherence to 
porcine enterocytes and the most potent interaction with F4ac fimbriae.  
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1 GENERAL INTRODUCTION 
 
In 2000, the World Health Organization announced the report on infectious diseases entitled 
“Overcoming antimicrobial resistance” and introduced the world to a new phenomenon that 
threatened to shake the foundations of modern medicine. The 3rd
“The History of Medicine: 
 chapter of this report begins 
with an anonymous quote: 
2000 B.C.  Here, eat this root. 
1000 A.D.  That root is heathen. Here, say this prayer. 
1850 A.D.  That prayer is superstition. Here, drink this potion. 
1920 A.D.  That potion is snake oil. Here, swallow this pill. 
1945 A.D.  That pill is ineffective. Here, take this penicillin. 
1955 A.D.  Oops . . . bugs mutated. Here, take this tetracycline. 
1960-1999 A.D.  39 more “oops.”. . . Here, take this more powerful antibiotic. 
2000 A.D.  The bugs have won! Here, eat this root” [1]. 
 
This humorous illustration poses a simplistic but realistic presentation of the long human 
history to fight infectious disease.  Nevertheless, infectious diseases continue to be the principal 
cause of morbidity and mortality on our planet. There are many reasons for this, but the 
phenomenon of antimicrobial resistance, has allowed many strains of bacteria to become 
resistant to almost all available drugs. This has become a leading global public health concern 
both in human and veterinary medicine [2].  
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The antimicrobial agents in veterinary medicine are used as growth promoters, prophylactics 
and as therapeutic agents. When used to promote growth, low doses of antimicrobial agents are 
introduced into the feed of healthy animals for a long period of time. For prophylactic purposes 
they are used, at either low doses or therapeutic doses, to prevent infectious disease or control the 
dissemination of already diagnosed infectious disease within a group of animals. In addition, 
medicated feed is used worldwide for treatment of sick herds. The swine and poultry industry are 
especially affected with this practice, because individual sick animals are difficult to treat [3]. All 
of these approaches may result in the overuse or misuse of antibiotics and development of 
bacterial resistance [4].  
The emergence of antimicrobial resistance of enterotoxigenic E. coli (ETEC), the cause of 
porcine post-weaning diarrhea (PWD), has become the focus of attention because of the 
increased incidence of this disease in the modern swine industry [5]. The E. coli isolates are 
multiresistant to a range of antimicrobials including oral and injectable antibiotics, especially 
those frequently used in treatment against PWD, such as apramycin, neomycin, spectinomycin 
and trimethoprimsulfonamide [6]. The ban on the use of antibiotics as growth promoters 
(avoparcin, bacitracin, spiromycin, tylosin, and virginiamycin) in European countries resulted in 
a higher incidence of PWD. The consequence of this ban was the increase in therapeutic use of 
aminoglycosides, macrolides, and lincosamides, which in consequence has led to development of 
antimicrobial resistances in E. coli [7]. Therefore, in order to stop antimicrobial resistance in 
enterotoxigenic E. coli associated with PWD, many alternative strategies for prevention and 
control have been examined to this point.  
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The aim of studies presented in this thesis was to investigate proteins of porcine milk fat 
globule membrane (MFGM), which was previously demonstrated to be able to interact [8] and 
inhibit attachment of ETEC to the intestinal brush border [9]. The protective function of
colostrum and milk immunoglobulins is well characterized and indisputable. However, both 
colostrum and milk also contain a myriad of non-immunoglobulin related substances potentially 
involved in protection of neonates against infectious diseases. Our research group isolated from 
porcine skim milk several F4-fimbrial-binding proteins, two of which, namely lactadherin and 
heart fatty acid binding protein, are major MFGM proteins in several species [10]. Subsequently, 
it was demonstrated that lactadherin interfered with attachment of F4-positive ETEC to porcine 
small intestinal villi ex vivo [11]. Since MFGM contains many proteins, it is reasonable to 
hypothesize that lactadherin is not the only one that interacts with F4-fimbriae. Accordingly, the 
first objective of this study was to investigate F4-fimbrial-binding proteins in porcine MFGM by 
affinity chromatography. The second objective was to determine inhibitory effects of F4-
fimbrial-binding proteins in porcine MFGM on attachment of F4ac ETEC to primary porcine 
enterocytes and porcine small intestinal epithelial cell line (IPEC-J2) using ELISA. 
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2 LITERATURE REVIEW 
 
2.1 Post-weaning diarrhea in pigs 
 
It’s been almost a half of century, since Sojka (1965) started to study porcine post-weaning 
diarrhea (PWD), but this disease still causes significant economic losses in the modern swine 
industry. Many studies have investigated the etiology [12], epidemiology [13], pathogenesis [14] 
and prevention [5] of porcine PWD, yet it seems that new and more effective strategies for 
prevention and control of PWD are needed in intense swine production.  
Porcine PWD, also known as post-weaning enteric colibacillosis, is infectious diarrhea 
primarily caused by enterotoxigenic Escherichia coli (ETEC). O149 serogroup is by far the most 
dominant ETEC involved in pathogenesis of PWD [15]. Among various strains of ETEC, only 
two can be found worldwide as a cause of PWD, namely F4 and F18. They are identified in 
92.7% of all ETEC related cases of PWD [12]. Another pathotype of E. coli involved in the 
etiology of this disease, to a lesser degree, is enteropathogenic E. coli [5].  
During the first week after weaning, the piglets are most susceptible to PWD due to many 
stress factors involved (stress of weaning, dietary changes) and lack of antibodies and potentially 
other protective substances from a sow’s milk. The strains of ETEC (F4 and F18) also have a 
significant effect on the timing of PWD outbreaks. The F4 strain can cause neonatal, preweaning 
and postweaning diarrhea; the postweaning diarrhea caused by F4 strain occurs most often 
within a few days after weaning. On the other hand, F18 strain more often causes PWD between 
5 and 14 days after weaning or even at introduction of pigs to finishing herds [15].  
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The typical clinical signs of PWD include sudden onset of watery (secretory) diarrhea that 
begins 16-36 hours after infection, lethargy, and cyanosis of the tip of the nose, the ears, and the 
abdomen [14]. If prolonged, dehydration and depression due to diarrhea can result in severe 
growth retardation. Sudden death can also occur occasionally during the first few days after 
weaning [15].  
The PWD is a disease characterized by high morbidity and variable mortality. Gross lesions in 
animals that died due to acute or subacute PWD may include: congested, flaccid small intestines 
affected sometimes by acute catarrhal enteritis and gastric venous infarction.  Microscopically, 
the most prominent change is the presence of small clumps or even continuous layers of ETEC 
(isolated in almost pure culture) attached to the surface of enterocytes on villi of the small 
intestine [16]. 
 
2.1.1 Pathogenesis 
 
There are two distinct steps in development of porcine post-weaning diarrhea caused by 
ETEC, namely, colonization and production of enterotoxins. Colonization is the first step in 
pathogenesis and starts with attachment of previously ingested ETEC from contaminated feed, 
water or environment, to small intestine.  The proliferation of a sufficient number of bacteria on 
the mid-jejunal and ileal intestinal surface is the essential requirement for development of PWD 
[5]. Adhesion of ETEC to the cell membrane of enterocytes is mediated by the interaction 
between fimbriae and specific receptors on the enterocytes [17]. Intestinal receptors for F4 
fimbriae are present in susceptible pigs from birth to adult age. For this reason, F4 positive 
ETEC can cause diarrhea in neonatal, postweaning and even finisher pigs. On the other hand, the 
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F18 strain of ETEC cause PWD only in pigs older than 3 weeks [5], because F18 receptors are 
expressed in piglets after 20 days of age [14].  
The second step in the pathogenesis of PWD is the development of secretory diarrhea induced 
by enterotoxins produced by colonized ETEC on the small intestinal surface. The enterotoxins 
cause the change in the water and electrolyte flux of the small intestine resulting in excess fluid 
in the large intestine, and diarrhea. The F4 strain of ETEC produces heat-labile (LT), heat-stable 
(ST), and EAST 1 enterotoxins [14].  
Heat-labile enterotoxin has 5 B-subunits and one A-subunit (A1 and A2 fragments). B-
subunits are responsible for binding to GM1 gangliosides receptors, while A-subunit (A1) has 
enzymatic activity (ADP–ribosyl transferase) that stimulates production of cyclic adenosine 
monophosphate (cAMP). After LT enterotoxin is internalized in the cell by receptor-mediated 
endocytosis, and undergoes retrograde transport through the endoplasmic reticulum, A1 fragment 
is released into the cytosol. The A1 fragment moves to the cytoplasmic face of the basolateral 
membrane and transfers the ADP–ribose moiety from nicotinamide adenine dinucleotide (NAD) 
to the Gs protein that stimulates adenylate cyclase. The end result is an excessive level of cAMP, 
as ATP is converted by adenylate cyclase to cAMP [5]. Cyclic AMP acts via stimulation of A 
kinase with direct phosphorylation and activation of the major chloride channel in intestinal 
epithelial cells, the cystic fibrosis transmembrane conductance regulator (CFTR) [18]. The active 
secretion of Cl- ions by chloride channels on the apical membrane of the cell causes a decrease in 
the levels of Cl- ions in the cell. This electrochemical gradient generated by the exit of Cl- ions 
drives the Na+-2Cl--K+ cotransporter on the basolateral membrane to transport more Cl- ions into 
the cell [19].  Additionally, the increased levels of cAMP,  active apical chloride secretion and 
increased sodium entry into the cell by the Na+-2Cl--K+ cotransporter, increases the activity of 
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the  Na+-K+ ATPase.  This pump helps maintain the resting membrane potential by intensively 
pumping 3 sodium ions out and 2 potassuim ions into the cell, regenerating the ion gradient.  
This allows the continued increased transport of Cl- ions through the Na+ -2Cl- -K+
Heat-stabile enterotoxin, STa binds guanylyl cyclase C protein, which results in activation of 
guanylate cyclase and increased levels of cyclic guanosine monophosphate (cGMP) inside 
enterocytes. Production of cyclic guanosine monophosphate (cGMP) facilitates the passage of 
chloride out of the cell and reducing the absorption of water from the intestine by activating 
chloride channel, CFTR.  
 cotransporter 
into the cell [20]. All of these activities together contribute to a significant increase in chloride 
secretion, which creates the osmotic drive for the massive loss of water into the intestinal lumen. 
LT and  STa enterotoxins both have effect on the activity of the enteric nervous system by 
stimulating serotonin (5-HT) release from intestinal enterochromaffin cells  [18]. Excessive 
levels of serotonin can either directly stimulate intestinal epithelial cell Cl-
 EAST 1 is a commonly found enterotoxin in the F4 strain of ETEC pigs with diarrhea; it 
shares considerable amino acid sequence homology with the STa toxin. Hence, it is believed that 
EAST 1 causes diarrhea by the same mechanism as STa [21]. However, purified EAST1 from 
enteroaggregative E. coli did not show biological activity in the suckling mouse assay that 
detects STa activity [22]. In addition to that, it is demonstrated that among all strains of different 
pathotypes of enterotoxigenic E. coli, when inoculated into newborn colostrum-deprived pigs, 
 ions secretion or 
indirectly by initiating release of neurotransmitters such as acetylcholine (ACh), VIP, and nitric 
oxide (NO) from myenteric and submucosal plexus.  The latter effect of serotonin will enhanced 
the blood flow into the intestine due the vasodilatation induced by VIP and NO, which will 
additionally contribute in maintaining high secretory rates during diarrhea [20]. 
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only EAST1 positive strain did not induce diarrhea [23]. Therefore, further investigations are 
needed to explain its role in ETEC associated with PWD.   
   
 
2.1.2 The fimbriae of ETEC 
 
In 1955, Duguid demonstrated that the agglutinating properties of E. coli are associated with 
the long non-flagellar filamentous appendages on the bacterial surface. They were called 
fimbriae [24]. 
A fimbria (plural fimbriae) is a long proteinaceous appendage radiating from the surface of 
the bacterium to a length of 0.5 to 1.5 nm [17]. The numbers of fimbriae can range from 100 to 
1000 per bacterium, and their distribution is peritrichous (around the entire surface of bacteria). 
In the past, terms fimbriae and pili were used interchangeably, but morphologically and 
functionally they are different. Fimbriae represent the group of proteinaceous surface 
appendages, which are thin (diameter 2-4 nm) and flexible with a poorly defined structure, while 
the pili are rigid morphological structures with a diameter of 7-8 nm and an axial hole [17]. 
Many types of fimbriae have been reported for E. coli, for example F4 [5], F5 [25], F6 [26], F18 
[5], F41[27]. However, only F4 and F18 positive ETEC strains are isolated from a majority of 
the cases of PWD in pigs. In addition, fimbrial adhesin called AIDA-1 (adhesin involved in 
diffuse adherence) has been identified in certain strains of ETEC associated with PWD [23]. 
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2.1.2.1 F4 fimbriae 
 
In 1961 Ørskov described the F4 fimbria and called it K88, according to capsular (K) antigen 
[28]. In 1966, Stirm isolated K88 by heating (60o
The F4 fimbria is a protein with a molecular weight of approximately 27 kDa, composed of 
many repeating major subunits known as FaeG and with a small number of minor subunits 
scattered throughout the structure. The minor subunits are FaeC, FaeD, FaeE, FaeF, FaeH, FaeI 
and FaeJ. While the major FaeG subunit is only responsible for its adhesive functions, minor 
subunits are involved in the process of fimbrial synthesis [30-31]. Based on differences in 
primary amino acid sequences of the major FaeG subunit, F4 strains are separated into 3 
serological variants, F4ab, F4ac and F4ad. The “a” determinant refers to an antigenically 
conserved segment and “b”, “c”, and “d” determinants to variable antigenic segments of F4 
fimbria [17].  
 C) and homogenizing bacterial culture and 
demonstrated that it was a protein. Electron microscopy showed that K88 was not a capsular 
antigen, but a flexible fimbrial structure with a diameter of 2.1 nm [29]. Therefore, the 
nomenclature changed from the K (Kapsula) to F (Fimbria) designation.  
There are 6 different phenotypes of pigs regarding the differences in their susceptibility 
towards different variants of F4 strains [32]. Phenotype A pigs are susceptible to all three F4 
variants, phenotype B only to F4ab and F4ac, while phenotype C pigs are susceptible to F4ab 
and F4ad. Phenotype D pigs are only susceptible to F4ad variant and phenotype F pigs to the 
F4ab variant. The affinity of phenotype E pigs has not been confirmed so far to any variant of F4 
strain [33].  
All F4 variant strains, especially F4ac adhere significantly more to jejunal than to duodenal 
villi [34]. This is because the majority of receptors are present in the mid-small intestine. In the 
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proximal and distal part of the small intestine, they are present in smaller amounts and entirely 
absent in the caecum and colon of susceptible pigs [35].  
The most intriguing feature of F4 fimbrial intestinal receptors is their structure. Intestinal 
brush border receptors for F4 fimbriae are characterized as glycoconjugates [17]. Sellwood 
suggested that the receptors are either glycoproteins or glycolipids in nature, because β-D-
galactose and periodate oxidation significantly interfere with their activity [36]. 
Furthermore, Gal β 1-3GalNAc and Fucα1-2Gal β 1-3/4GlcNAc oligosaccharide sequences 
are proposed to mediate the binding of receptors to F4ac fimbriae [37]. The F4ac variant of 
ETEC is the most widespread strain of ETEC that causes PWD [38].  
 
2.1.2.2 F18 fimbriae 
 
The F18 strain of ETEC also causes PWD worldwide. F18 fimbriae are long, flexible 
structures, characterized by a zigzag pattern. They mediate adherence to the intestinal epithelium 
in pigs older than 3 weeks of age, and not in younger pigs [14]. In the past, this strain was 
designated also as F107, 2134P or 8813, but now it is known that those are different names for 
two antigenically different variants of F18, namely F18ab and F18ac [5]. The F18ac variant is 
easily expressed in vitro and it is more commonly isolated from PWD cases than the F18ab 
variant, which is expressed poorly in vitro [14].  
F18 positive ETEC strains regularly produce heat-stable enterotoxins STa and STb, but rarely 
heat-labile enterotoxin (LT) [39]. Structurally, F18 is comprised of a major subunit FedA, and a 
minor subunit, such as FedF that is responsible for adhesion [40]. The nature of the F18 receptor 
is unclear, however, it is suspected that H-2 histo-blood group antigens (HBGAs) and A-2 
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HBGAs may be involved in the binding of F18 positive E. coli to the host [41]. Some pigs are 
resistant to colonization by F18 positive ETEC due to the lack of receptors for F18 [12]. 
 
2.2 The prevention and control strategies for PWD 
 
In the recent years, attempts to find the most effective strategy for prevention and control of 
PWD have intensified, attracting the interest of many researchers. The reason for that lies 
primarily in the fact that control of PWD by prophylactic antibiotic treatments done for years is 
not effective anymore due to the emergence of antimicrobial resistance [5]. Pressure to reduce 
the use of antibiotics in animal production and to explore alternative strategies is growing from 
year to year as the number of resistant bacteria in the intestine of animals increases [42]. The 
focus of this review will be on major preventive initiatives. 
 
2.2.1 Chemoprophylaxis  
 
During the course of PWD, pigs must be treated parenterally, because they eat or drink very 
little. Hence, antimicrobial substances have to be able to reach the intestinal lumen to control 
bacterial proliferation. The most commonly used antibiotics are amoxicillin/clavulanic acid, 
fluoroquinolones, cephalosporins, apramycin, ceftiofur, neomycin, or trimethoprim [15]. Due to 
the nature of the swine industry, there is the widespread practice of using these antimicrobial 
agents for preventive feed medication of affected herds [5].  This prophylactic approach to PWD 
resulted in the development of bacterial resistance to apramycin, neomycin, and trimethoprim or 
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trimethoprim-sulfamethoxazole [43]. Therefore, this approach for prevention and control of 
PWD has become unattractive.  
 
2.2.2 Management 
 
The major management measures for prevention and control of PWD are focused on hygiene 
and reduction of stress. In particular, the environment of the weaner units plays an important role 
in the epidemiology of PWD, as a major source of ETEC and stress for weaned piglets. Hence, 
general management measures are aimed at reducing any form of stress, such as transportation, 
chilling, mixing of litters, and introduction to new pens [15]. Another important factor is 
weaning age of piglets, which has been steadily decreasing in North American swine farms.  
This time has been reduced from previous practice of 5-6 weeks, to the current 3 weeks of age, 
or even less [44]. Particularly, early weaning  represents a risk factor for development of PWD, 
because piglets do not develop strong humoral immunity for protection against ETEC infection 
before 12 weeks of age [45]. Routine cleaning and disinfection are usually insufficient to break 
the cycle of infection [46], but the transmission of PWD can be prevented by strict hygienic 
measures [15].  
 
2.2.3 Breeding of resistant pigs 
 
Not all pigs are susceptible to F4 and F18 strains of ETEC. Susceptibility and resistance of 
pigs to infection is closely associated with the ability of ETEC to colonize intestinal epithelium. 
Thus, in resistant pigs small numbers of ETEC bind to enterocytes and produce enterotoxins, 
however the amount is not sufficient to induce secretory diarrhea. This phenomenon can be 
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explained either by a small number of receptors present in the brush borders, or non-functional 
receptors that are not capable of binding bacteria [33].  Nevertheless, resistance of pigs to ETEC 
infection is inherited via an autosomal recessive gene [47]. This fact has stimulated researchers 
to consider breeding of resistant pigs as one of preventive strategies against PWD. Regardless of 
the current progress of this approach, there are certain disadvantages to it, such as risk of co-
selection of unwanted traits closely linked with loci coding for the F4 and the F18 receptors, 
emergence of new adhesive variants of ETEC and lack of economical laboratory techniques for 
large-scale selection of resistant pigs. It is known that F4 strain resistant sows do not secrete F4 
specific antibodies in colostrum, so heterozygous piglets may be at a higher risk of developing 
neonatal diarrhea [5].  
 
 
2.2.4 Immunoprophylaxis 
 
Immunoprophylaxis against PWD is achieved by passive and/or active immunotherapy. 
Insufficient passive immunity acquired from the sow is one of the main factors that contributes 
to PWD. There are several strategies that can be employed to improve it. Ingestion of anti-F4 or 
anti-F18 specific antibodies in weaned piglets has been achieved by adding dried porcine blood 
plasma [48] or chicken egg yolk [49] to post-weaning feed. These two approaches were 
implemented based on previous studies demonstrating that intestinal colonization with ETEC 
was inhibited in weaned pigs fed with supplementary porcine milk [50]. Although the feed 
additives based on dried porcine blood plasma demonstrated significant inhibitory effect on 
ETEC colonization with subsequent prevention of PWD, they showed as an expensive strategy 
for control of PWD. Furthermore, they were banned in Europe due to potential health risks, 
being sub-product of animal origin [5]. On the other hand, use of chicken yolk is a relatively 
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inexpensive strategy, because large quantities of specific IgY antibodies can easily be produced. 
When weaned pigs, fed with egg-yolk antibodies from chickens immunized with purified F4  are 
challenged with F4-positive ETEC, they are affected only by transient diarrhea and no mortality, 
in comparison to control piglets [49].  
The active immunization of sows (e.g. Escherichia coli bacterin vaccine
There are two types of vaccination protocols against porcine colibacillosis. Maternal 
vaccination  with a combination of fimbrial antigens and oral immunization of piglets with either 
live attenuated or live wild-type avirulent E. coli strains [51]. In the first protocol, active 
immunization of sows incites more systemic and less mucosal immunological protection in 
piglets, and appears to be not entirely effective against colonization of ETEC [52]. Furthermore, 
it can potentially suppress the mucosal immune response of subsequent oral immunization  [53]. 
However, the presence of specific F4 antibodies in colostrum and milk during the suckling 
period has proven to protect piglets against ETEC intestinal colonization [50]. 
) is the most effective 
current strategy for control of neonatal diarrhea induced by ETEC.  However, at the present time, 
there is no commercial vaccine that can fully protect weaned pigs against PWD.  
Some studies demonstrated that use of purified F4 fimbriae as the antigen (oral subunit 
vaccines) is more effective in stimulating the mucosal immune response  [54] than attenuated E. 
coli. Ingested F4 fimbriae were demonstrated to have a strong immunogenicity resulting in 
production of antibody of IgM isotype in Peyer’s patches, lamina propria, mediastinal lymph 
nodes, and blood. Administration of these vaccines in drinking water to weaned or unweaned 
piglets one week before the expected onset of diarrhea was demonstrated to prevent intestinal 
colonization of ETEC [54]. Accordingly, the F4 fimbriae and/or its major subunit FaeG continue 
to be exploited for development of new vaccines. For example, incorporation of the FaeG 
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subunit into feed through genetic modification of plants, such as alfalfa or transgenic tobacco, 
has been successful [55-56]. Joensuu et al., demonstrated that FaeG adhesins, synthesized in the 
tobacco plant and in alfalfa were stable in piglet gastric and intestinal in vitro conditions and 
could bind isolated piglet villi and inhibit subsequent F4 positive ETEC binding. However, 
immunization of piglets with recombinant FaeG adhesin induced a weak F4 specific humoral 
response [55-56]. On the other hand, the recombinant glycosylated FaeG expressed in barley 
endosperm was able to induce biologically active F4 specific antibodies in mice [57]. Based on 
these encouraging results it is anticipated that these research strategies may contribute to the 
future prevention of PWD in the modern swine industry. 
 
2.2.5 Probiotics 
 
Probiotics represent a large group of feed supplements containing live microorganisms, which 
positively affect the host intestinal health. There are several mechanisms believed to be 
responsible for the beneficial effects of probiotics on intestinal microflora [58]. The first 
mechanism involves the competition between probiotic and pathogenic microorganisms for 
attachment to intestinal epithelial receptors [59] resulting in reduced colonization of pathogens 
and prevention of the disease. The second mechanism is the potential effect of probiotics on 
nutrients from feed in the intestine, making them easily digestible and more available for 
absorption. In addition, probiotics  synthesize antimicrobial substances and other inhibitors thus 
affecting growth of pathogens in the intestine [60]. Finally, it has been confirmed that they 
stimulate the local immune system resulting in increased secretion of immunoglobulins [61], and 
production of cytokines  [62]. 
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Use of the probiotics in prophylaxis of PWD currently attracts the great interest among many 
researchers. Many studies have explored the effect of probiotics on ETEC and PWD by testing 
various combinations of strains of bacteria, doses, and interactions with pharmaceuticals [5, 63-
66]. It has been confirmed that use of Rhizopus-fermented or Bacillus-fermented soybeans 
(viable spores of Bacillus licheniformis and Bacillus toyoi)  reduced the severity, duration and 
mortality of PWD in piglets [67].  Recently, there are reports that lactic acid producing bacteria, 
Pediococcus acidilactici and yeasts, Saccharomyces cerevisiae boulardii improve intestinal 
defences against F4 positive ETEC, by reducing ETEC F4 attachment to the intestine and by 
increasing production of proinflammatory cytokines involved in innate immunity against F4 
positive ETEC. If used together, P. acidilactici and S. cerevisiae boulardii can increase 
significantly the expression of IL-6, IL-8 and TNF-α in the ileum of the pigs challenged with F4 
E. coli  [65]. It is confirmed that intestinal epithelial cells secrete these cytokines and that they 
play an important role in stimulation of  local B-cells to produce IgA [68]. 
 
2.2.6 Prebiotics 
 
Prebiotics are non-digestible food ingredients (e.g. non-starch polysaccharides, dextrins, 
inulin, lignin, waxes, pectins, beta-glucans, and oligosaccharides) able to stimulate the 
proliferation of probiotics in the gastrointestinal tract [66]. Their mechanism for stimulation of 
the growth of lactic acid and bifidobacteria (genus Bifidobacterium) is based on the ability to 
increase the volatile fatty acid, lactic acid and ammonia content in the digestive tract [69].  
The most used and studied prebiotics to date are mannanoligosaccharides (MOS). They are 
isolated from the yeast cell wall and their protective effects are achieved by preventing the 
binding of pathogens to intestinal epithelial receptors [63]. In addition, MOS inhibit the growth 
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of different pathogens (E. coli, Salmonella typhimurium, Clostridium botulinum and C. 
sporogenes), stimulate the proliferation of probiotics (Lactobacillus casei, L. acidophillus and L. 
delbrücke) and incite a mucosal immune system response [58]. It has been confirmed that MOS 
have positive effects on the growth performance and overall health status of weaned pig [70].  
There are reports about positive effects on human and animal health with other prebiotics 
such as fructooligosaccharides, galactooligosaccharides, and xylooligosaccharides [66, 71-73].  
The prebiotic activity of fructooligosaccharides has been confirmed in animal and human 
trials [66]. The general mechanism of their action is by promoting growth of bifidobacteria in the 
human colon, which can result in excretion of natural antimicrobial activity against various 
Gram-positive and Gram-negative intestinal pathogens [66]. The combination of Lactobacillus 
plantarum, maltodextrin and fructooligosaccharides given orally to suckling piglets has proven 
to inhibit the adhesion of E. coli O8:K88 to the mucosa of the jejunum, ileum and colon [74]. 
Galactooligosaccharides and xylooligosaccharides are non-digestible and acid-stable 
carbohydrates [66]. They have shown the ability to significantly inhibit adhesion of L. 
monocytogenes to the intestinal epithelium in vitro [75] and decrease the numbers of intestinal L. 
monocytogenes in ileal samples from guinea pigs in vivo [76]. However, their potential use for 
prevention and control of PWD has never been reported and needs to be explored more in the 
future. 
 
2.2.7 Non-antibiotic substances 
 
There is a wide range of different non-antibiotic substances described in the literature and 
considered as potential alternatives in the prophylaxis of PWD.  
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Zinc oxide is a remarkably potent medication for prevention of PWD [5]. Its ability to 
efficiently reduce diarrhea and mortality as well as improve growth in pigs is related to many 
dietetic properties of zinc [5]. Zinc is a component of many enzymes responsible for amino-acid 
and protein metabolism [77]. Hence, it stabilizes intestinal mucosa, improves the diversity and 
functions of intestinal microflora, inhibits the growth of many pathogens and enhances the 
immune responses of the body against infections [78-81]. However, if high levels are used, there 
is a potential environmental risk for heavy metal contamination of the soil [5].  
Certain organic acids in feed have antibacterial and antifungal properties, so they are 
commonly used in animal nutrition [58]. The antimicrobial effect of organic acids is associated 
with their ability to decrease feed pH, penetrate the cell wall and destroy microorganisms [82]. 
Growth rate and efficiency of feed conversion is significantly improved in weaned pigs by 
supplementing starter diets with a pure formic acid [83], or mixtures of organic acids (formic, 
citric, propionic and benzoic acids) [84]. In addition, piglets fed diets supplemented with organic 
acids (1.6 % lactic acid, 1.2% formic acid, 1.2% malic acid, 1.5% citric acid or 1.5% fumaric 
acid) had reduced incidence and severity of post-weaning diarrhea [85].  
For centuries, various plants extracts have been used for treatment of human and animal 
diseases in traditional medicine. Recently, all of them are classified under the one group, natural 
feed additives (plants and spices), and they have started to attract considerable attention as 
alternatives to antibiotics [58]. Various antimicrobial, anti-inflammatory, anti-oxidative and anti-
parasitic properties of these substances have been described in the literature [86-88].  
Garlic, thyme, oregano, cloves, cinnamon, juniper extracts and plant essential oils are all 
considered as potentially very effective antimicrobials [58]. Bromelain, a protease from 
pineapple stems, if orally administered to pigs, can reduce the colonization by F4 positive ETEC 
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[89] and reduce the incidence of post-weaning diarrhea [90]. Nevertheless, a major disadvantage 
of plant extracts lies in the fact that they are unstable in feed formulations [91].  
Use of natural and modified clay minerals in prophylaxis of enteric disease is an emerging 
research area. The natural clays (bentonite, zeolite, kaolin, etc.) possess high adsorption capacity, 
due to their stratified structure. Consequently, if added to a diet, they can bind and immobilize 
toxic materials and decrease their biological availability and toxicity in the gastrointestinal tract 
of animals [92]. Kaolin-based medications are already used in human medicine for the therapy of 
enteric diseases [93-94]. In the literature, there are reports that a Cu2+
The variety of strategies presented in this section indicates that several alternative approaches 
have been proposed and their effectiveness is variable for prevention of PWD. However, at this 
time, not a single strategy has been proven to be absolutely effective [5], which makes this 
disease even more attractive for some future research ventures.  
-enriched clay mineral, 
such as montmorillonite that significantly decreased the incidence of post-weaning diarrhea in 
piglets [95]. 
 
2.3 Potential protective substances in porcine milk against PWD 
 
Although the chemical and nutritional composition of porcine milk has been evaluated 
extensively [96-97], relatively little is known about its non-immunoglobulin protective properties 
against gastrointestinal diseases. There are a few studies reporting various potential substances in 
porcine milk that are able to inhibit the colonization and growth of various pathogens, including 
ETEC [11, 98-99].  
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As previously described for human milk [100], the following main potential antimicrobial 
components of porcine milk will be reviewed: antibodies, multifunctional agents, and 
homologues of host cell surface glycoconjugates. 
 
2.3.1 Immunoglobulins 
 
The immunoglobulin (Ig) content in porcine milk significantly changes throughout lactation. 
Colostrum has a high concentration of Ig (~125.9 g/L), which markedly declines during the first 
few days of lactation (~7.3 g/L). The major classes of Ig in porcine colostrum and milk are IgG, 
IgM and IgA. IgG concentration is highest in colostrum (~61.8 g/L) and starts to decrease as 
lactation progresses (after 42 days, ~0.8  g/L), while an increase as lactation progresses in the 
concentration of IgM is moderate (~1.4 g/L) and marked for IgA  (~5.6 g/L) (40% of total milk 
protein at the end of lactation) [96].  
Neonatal piglets are dependent on antibodies absorbed from colostrum right after the birth 
(within 24-36 hrs), because little or no placental transfer of antibodies occurs during gestation 
[101-102].  
Humoral immunity against  ETEC infection in pigs is delivered  through sow’s colostrum, 
antibodies in milk, and later in life through the intestinal mucosal immune response [15]. During 
a sow’s pregnancy, intestinal lymphocytes stimulated by ETEC antigens, migrate to the 
mammary gland and produce specific IgA, IgM and IgG. Even though neonatal piglets in their 
first weeks of life begin to synthesize mucosal IgM and later IgA, this is not sufficient for 
immunological protection. Hence, colostrum and milk remain major sources of Ig for protection 
against ETEC infection [45]. If piglets fail to receive sow’s colostrum and milk in early lactation,  
due to piglet deformities, sow’s non-exposure to ETEC, agalactia, or generalized infection, they 
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will be highly susceptible to ETEC infections [15]. Weaned piglets fed with milk obtained from 
sows in late lactation were protected against colonization of ETEC and did not develop PWD 
[50]. This confirms that immunoglobulins and potentially other non-immunoglobulin substances 
present in porcine milk are most likely responsible for protection of piglets against ETEC 
infection. 
 
2.3.2 Multifunctional agents 
 
Multifunctional agents, sometimes termed bioactive substances, are considered an important 
part of the innate immunity of milk. These components provide neonates primarily with 
nutrients, but some of them, either in their native form or partially digested,  can provide a broad 
range of protection for newborns against infection [103]. Lactoferrin, lysozyme, monoglycerides 
and fatty acids are the best known in the literature at this time. 
 
2.3.2.1 Lactoferrin 
 
Lactoferrin in porcine milk is an iron-binding glycoprotein with a molecular weight of 74.5 
kDa. The concentration of lactoferrin at parturition ranges from 1.1-1.3 mg/ml, but the level 
decreases sharply during the first week of lactation [96]. The biological role of lactoferrin is not 
entirely clear, but the literature indicates that this multifunctional protein has broad antimicrobial 
and anti-inflammatory properties [104]. Bacteriostatic and bactericidal effects of lactoferrin are 
directed against a variety of microorganisms, including several strains of Escherichia coli [105-
106]. The iron-free form of lactoferrin has a bacteriostatic effect, based on its ability to deprive 
the bacteria of unbound iron, making it unavailable for their metabolic activities in vivo [103]. 
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The bactericidal activity of lactoferrin is still not definitively explained, but it is documented that 
lactoferrin causes a significant release of lipopolysaccharide (LPS), and damages the outer 
membrane of Gram-negative bacteria [107]. Also, it enhances the antibacterial activity of other 
multifunctional agents, such as lysozyme [108]. Pepsin digestion of lactoferrin produces 
lactoferricin B, a positively charged peptide of 18 amino acids with potent antibacterial activity 
for a wide spectrum of bacterial pathogens [103]. Oral administration of bovine lactoferrin to 
pigs demonstrated protection against endotoxic shock [109]. Porcine lactoferrin has affinity for 
LPS isolated from F4 positive Escherichia coli [99]. 
Another protective milk protein and part of innate immunity is lysozyme.  In human milk the 
amount of lysozyme varies from 10 to 100 µg/L. Lysozyme damages cell walls of Gram-
negative bacteria by a breaking critical linkage in the peptidoglycans of bacterial cell walls 
[103]. 
Triglycerides in milk provide mainly energy for newborns. However, when they are digested 
into fatty acids (linoleic and lauric acid) and monoglycerides, they also act as strong detergents 
for pathogen membranes [103]. 
 
2.3.3 Glycoconjugates 
 
Glycoconjugates in milk consist of a wide group of molecules exclusively found in large 
amounts at early stages of lactation [110]. These components possess conjugated carbohydrate 
moieties, which often have a similar or identical structural pattern as host target cell receptors 
specific for pathogen adherence. Hence, they are sometimes referred to in the literature as 
homologues of cell surface glycoconjugates and a potentially significant component of innate 
immunity [111]. Moreover, some authors hypothesize that in newborns, glycoconjugates and 
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multifunctional agents form a primary line of defense against enteric pathogens during  a period 
that occurs between the time of the mother’s exposure to the pathogen and production of 
secretory antibodies against it in her milk [112]. Glycoproteins, glycolipids, and oligosaccharides 
play the largest role among them [100].  
Several oligosaccharides and glycoproteins from human milk have been shown to block 
binding of specific pathogens to host cell receptors [112]. Particularly, the fucosylated 
oligosaccharide fraction of human milk demonstrated  inhibition of adherence of Streptococcus 
pneumoniae to target cells in vitro [113]. In addition, it was confirmed that they can block the 
binding of a heat-stable toxin of enteropathogenic Escherichia coli to the extracellular portion of 
guanylate cyclase in vitro, which can be beneficial for prevention of secretory diarrhea in infants 
[114].  Fucosylated structures also inhibit binding of Campylobacter jejuni
 
 to host cell receptors 
and limit its colonization in vivo [100]. Binding of Norwalk virus to the duodenal enterocytes of  
infants can be blocked by α1,2-fucosyl glycans from human milk in vitro [112]. Human 
lactadherin inhibits binding of all major strains of human rotavirus to their target cells 
subsequently preventing diarrhea in infants [115]. Porcine lactadherin was confirmed to have 
binding affinity for F4ac fimbriae and the ability to decrease binding of F4ac positive E. coli to 
intestinal villi ex vivo [11]. Lactadherin is a major protein of Milk Fat Globule Membrane 
(MFGM) [10]. 
2.3.3.1 Milk fat globule membrane proteins 
 
The lipids in the milk are secreted as droplets coated with a cellular membrane, called milk fat 
globule membrane (MFGM). These membranes consist of three layers that encase a central 
triglyceride core. The interior layer originates from the endoplasmic reticulum of lactating 
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mammary epithelium. The outer surface of milk fat globule is formed of two layers consisting of 
various proteins and polar lipids derived from apical membranes of the glandular epithelial cells 
[116]. The proteins associated with the milk fat globule membrane are called MFGM proteins. In 
this section, only major proteins identified in porcine milk will be reviewed [117].  
Butyrophilin (BTN) is the most abundant protein of MFGM in many species, including pigs 
[10, 117]. Butyrophilin is an integral, type I membrane glycoprotein having a molecular weight 
of approximately 60 kDa [118]. The role of BTN in porcine milk is still not entirely explained, 
but in other species is well documented. It was hypothesized that a complex formed between 
BTN, xanthine dehydrogenase (XDH) and adipophilin (ADPH) in MFGM is primarily 
responsible for regulation of milk fat secretion [119-120]. However, recent studies suggest that 
BTN has an essential role in regulation of secretion of milk fat [121]. If the BTN gene is 
eliminated in mice, milk fat will lack MFGM, and will be highly unstable (extremely large lipid 
droplets), while the concentration of skim milk proteins will not be affected [122]. BTN belongs 
to the large immunoglobulin superfamily, which contains a many adhesive proteins with 
significant biological functions, such as receptors or inhibitors of T-cell activation [123-125]. 
There is a report that porcine BTN demonstrated significant binding capacity for F4ac fimbriae 
of ETEC during an in vitro study [117].  
Milk fat globule-epidermal growth factor-factor 8 (MFG-E8), also known as lactadherin 
(LAD) in humans, or PAS 6/7 in bovine, was initially discovered as a major component of the 
MFGM of several species, but later research revealed its ubiquitous pattern of expression in 
different cells and tissues [126]. Paradoxically, while functions of lactadherin in milk still remain 
undefined, research in other expression sites is thriving. The most remarkable function of LAD 
discovered up to now is its ability to promote the clearance of apoptotic cells by forming bonds 
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between phagocytes and apoptotic cells [119, 127]. LAD also promotes cellular adhesion, 
through interaction between its N-terminal epidermal growth factor (EGF)-like domain with 
RGD cell adhesion sequence and cell integrins [128]. LAD exhibits a proangiogenic effect 
(neovascularization) in tissue regeneration, because of its integrin-mediated signaling of vascular 
endothelial growth factor [129]. Human LAD possesses inhibition activity against all major 
strains of human rotavirus, a significant cause of diarrhea in infants, both in vitro and in vivo 
[115, 130]. LAD from porcine MFGM demonstrated high affinity for F4ac fimbriae, the 
potential to prevent binding of F4ac positive E. coli to intestinal villi ex vivo [11] and a strong 
interaction with F4ac fimbriae in vitro [117].  
Xanthine dehydrogenase/oxidase (XDH/XO) is a widely distributed protein in a variety of 
mammalian tissues. This complex cytosolic enzyme has been known for a long time as one of 
the major constituents of bovine MFGM, located along its inner layer. XDH/XO consists of two 
identical subunits of 147 kDa [131]. Each subunit contains one molecule of molybdenum, one of 
flavin adenine dinucleotide, and two iron-sulfur redox centers [132]. XDH/XO has a crucial role 
in purine catabolism, catalyzing the oxidation of hypoxanthine to xanthine and the oxidation of 
xanthine to uric acid [10]. Protein–protein interactions are documented to be responsible for the 
formation of a complex among XDH/XO, BTN, and ADPH, and regulation of secretion of milk 
fat. An experiment with knockout mice has revealed that XDH/XO and BTN are essential for 
milk fat secretion [119]. XDH/XO has two interconvertible forms, XDH, which predominates in 
vivo, and xanthine oxidase (XO). Both forms of the enzyme reduce molecular oxygen, and 
generate the reactive oxygen species (ROS), superoxide anion, and hydrogen peroxide. 
Therefore, XDH/XO has been described as a destructive agent in ischemia-reperfusion injuries, 
but moreover as a highly potent antimicrobial agent [131].  
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Perilipin 2, ADPH, or adipocyte differentiation-related protein, are all names for one protein 
implicated in the storage and metabolism of lipids in many species. In bovine MFGM, this 
protein is often overlooked, because of a similar molecular weight as LAD (46 kDa) [10]. 
Nevertheless, two-dimensional (2D) SDS-PAGE reveals their different isoelectric points [10]. 
ADPH can be generated in a variety of cells and tissues, not exclusively in adipocytes, but also 
in lactating mammary epithelial cells, Sertoli and Leydig cells in the testis, adrenal cortical cells, 
and others [133]. However, knowledge about physiological functions of ADPH is currently 
inadequate. The complex that forms between ADPH, BTN, and XDH/XO is described as related 
to regulation of secretion of fat in milk [119]. ADPH has a role in lipid biogenesis and cellular 
uptake of long-chain fatty acids [134-135]. In a recent study, ADPH exhibited strong binding 
ability for F4ac fimbriae of ETEC in vitro [117].  
Fatty acid binding protein (FABP), approximately 13 kDa, is a component of bovine MFGM 
[10]. Originally, FABP was identified as a growth inhibitor of mammary carcinoma cells, and 
called mammary-derived growth inhibitor [136]. FABP in MFGM is a member of the 
intracellular FABP family and is most similar to heart FABP [137]. Several roles of FABP are 
proposed, and all are associated with lipid metabolism [10]. FABP inhibits growth and stimulates 
differentiation of mammary gland epithelium [10]. Recently, it was demonstrated that FABP 
from porcine milk interacted with F4ac fimbriae of ETEC in vitro [11, 117].  
Acyl-CoA synthetase 3 (ACS3), also known as long-chain-fatty-acid-CoA ligase 3, and 
sometimes referred to inaccurately as Acyl-CoA carboxylase, is a minor protein of MFGM 
[138]. Functionally, it is regulatory enzyme, essential for de novo lipid synthesis, fatty acid 
catabolism, and remodeling of membranes [139]. Based on the length of the carbon chain of the 
fatty acids specific for the different acyl-CoA synthetases, five sub-families of ACS have been 
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characterized at this time. ACS belongs to the large long-chain fatty-acid-coenzyme A ligase 
family that activates the degradation of complex fatty acids [139]. It has been shown that several 
acyl-CoA synthetases, together with some other substances related to lipid transport synthesis 
and secretion, were upregulated up to 5 times in bovine MFGM obtained at the 7th day of 
lactation in comparison to colostrum MFGM [120]. Although ACS3 is present in porcine MFGM 
in small amounts compared to the other major proteins, it has showed a strong binding ability for 
F4ac fimbriae of ETEC in vitro [117]. In the future, more studies will be required to resolve all 
physiological roles of ACS of MFGM. 
Initially, Atroshi et al., reported that porcine MFGM can act as a target for binding of F4 
positive E. coli [8]. Furthermore, it was demonstrated that porcine milk MFGM have the 
potential to inhibit the binding of F4 fimbriae to porcine intestinal brush borders [9]. Recent 
studies revealed that certain proteins of porcine MFGM, such as lactadherin and fatty acid 
binding protein have binding affinity for F4ac fimbriae of ETEC [11], and that lactadherin, 
butyrophilin, adipophilin, and acyl-CoA synthetase 3 interact with F4ac-fimbriae in vitro as 
demonstrated by overlay Western blot technique [117].  
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3 RESEARCH HYPOTHESES AND OBJECTIVES 
 
3.1 Rationale 
 
F4ac positive enterotoxigenic Escherichia coli (ETEC) is one of the most common pathogens 
that can cause neonatal and post-weaning diarrhea in piglets. The attachment of ETEC to the 
intestinal brush border is an essential step in the pathogenesis. It is always mediated by the same 
filamentous surface appendages called F4 fimbriae. The major structural subunit of F4ac 
fimbriae is composed of a protein possessing adhesive properties.  However, sow milk contains 
many substances that can bind to F4ac preventing attachment of  ETEC to enterocytes. These 
substances range from antibodies specific for F4ac to non-immunoglobulin substances such as 
lactadherin. The lactadherin was primarily isolated as an F4ac-binding protein from porcine skim 
milk. Since this protein is one of the structural proteins of Milk Fat Globule Membrane 
(MFGM), there was a reasonable interest in F4-binding affinity of the other MFGM proteins, 
which was initially investigated by overlay Western blot technique [117] and subsequently 
confirmed by affinity chromatography in this thesis. 
 
3.2 Hypothesis 1 
 
In addition to lactadherin [11], there are other proteins of the MFGM, which interact with 
F4ac fimbriae of E. coli in their native configuration (i.e. with preserved quaternary, tertiary and 
secondary structures). 
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3.3 Objective 1 
 
To isolate and characterize F4ac-binding proteins of porcine MFGM by affinity 
chromatography. 
 
3.4 Hypothesis 2 
 
The F4ac–binding proteins isolated by affinity chromatography (objective 1) inhibit the 
attachment of enterotoxigenic E. coli to porcine enterocytes in vitro. 
 
3.5 Objective 2 
 
To evaluate the inhibitory effect of individual F4ac-binding MFGM proteins against 
attachment of F4ac-positive E. coli to porcine enterocytes in vitro by competitive ELISA. 
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4 IDENTIFICATION OF F4AC-BINDING PROTEINS OF PORCINE MILK FAT 
GLOBULE MEMBRANE 
 
The affinity chromatography results described in this chapter were merged with previous 
results generated in our lab (Chapter 3 of Dr. Huang’s MSc Thesis) and submitted for publication 
as the following manuscript: 
P. Novakovic *, Y.Y. Huang *
 
, B. Lockerbie, F. Shahriar, J. Kelly, D.J. Olson, J.R. Gordon, 
D.M. Middleton, M.E. Loewen, B.A. Kidney, E. Simko. Identification of F4ac-binding proteins 
of porcine milk fat globule membrane. Submitted to Developmental and Comparative 
Immunology. (* equal contribution) 
4.1 Introduction 
 
Enterotoxigenic Escherichia coli (ETEC) expressing the F4 is the most common bacterial 
pathogen that causes neonatal and post-weaning diarrhea (PWD) in piglets. At the present time, 
the F4ac variant of ETEC is the most dominant type worldwide [5]. An essential step in the 
pathogenesis of PWD is the attachment of ETEC to the intestinal brush border of weaned piglets. 
This attachment is mediated by bacterial filamentous surface appendages called F4 fimbriae. 
This mechanism of attachment enables the bacteria to resist peristalsis of the small intestine, in 
order to effectively colonize enterocytes and deliver enterotoxins [5]. The major subunit of F4 
fimbriae is a protein in nature with adhesive properties for carbohydrates. The porcine receptors 
for F4 fimbriae are glycoproteins and glycolipids found both on the intestinal brush border and 
within mucus [17, 140]. Binding between F4 fimbriae and specific intestinal receptors has 
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characteristics of lectin-carbohydrate interactions, in which the fimbriae bind to glycan moieties 
of glycoproteins [141].  
Sow milk contains substances that can bind to F4 fimbriae and potentially prevent 
colonization of ETEC to the intestine and subsequent development of PWD [50]. These 
substances range from antibodies specific against fimbrial antigens to non-immunoglobulin 
glycoproteins, such as lactadherin and fatty acid binding protein (FABP) [11]. Both, lactadherin 
and FABP originate from the structure that surrounds milk fat droplets, called milk fat globule 
membrane (MFGM) [10]. Previous studies reported that porcine MFGM can act as a target for 
binding of F4 positive E. coli [8]. In addition, it was demonstrated that porcine milk MFGM can 
inhibit the binding of F4 fimbriae to porcine intestinal brush borders [9]. A recent study using an 
overlay Western blot technique revealed that several porcine MFGM proteins interacted with 
F4ac fimbriae in vitro [117]. In this particular study MFGM proteins were separated by two-
dimensional electrophoresis (2D SDS PAGE); therefore their tertiary and secondary structures 
were destroyed by complex chemical treatments of samples subjected to 2D SDS PAGE. 
Accordingly, the purpose of this study was to investigate F4ac-fimbrial binding affinity of 
MFGM proteins not exposed to harsh chemical treatment using affinity chromatography. 
 
4.2 Material and methods 
 
4.2.1 Bacteria 
 
F4ac positive Escherichia coli (O149:K91:K88ac), isolated from a clinical outbreak of 
neonatal diarrhea of piglets, was kindly provided by Dr. Musangu Ngeleka, Prairie Diagnostic 
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Services Inc., University of Saskatchewan. Bacterial stocks in trypticase soy broth (TSB) 
(Becton Dickinson and Co, Sparks, MD) and glycerol (2:1) were prepared [142] and stored at –
70°C. 
4.2.2 Isolation of F4ac fimbriae 
 
F4ac fimbriae were isolated and purified according to a previously published method [143], 
the only modification being the introduction of filtration of solubilized F4ac fimbriae through 
0.20µm pore size filters (Nylon Membrane 0.2µm 47 mm PK/100, Millipore Corporation, MA, 
USA) before each step of precipitation at pH 4 during the purification process to prevent 
aggregation. Purified F4ac fimbriae were stored at -20°C in PBS (1.6 mM NaH2PO4, 9.4 mM 
Na2HPO4
 
, 154 mM NaCl, pH=7.2). The fimbrial concentration was determined with a Quick 
Star Bradford protein assay (Bio-Rad Laboratories, Mississauga, ON) using a Spectra Max 340 
PC Spectrophotometer with SoftMax Pro software (Molecular Devices Corporation, Sunnyvale, 
CA, USA). To determine purity of isolated F4-fimbriae, they were subjected to sodium dodecyl 
sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) and visualized with Coomassie stain. 
4.2.3 One-dimensional SDS-PAGE 
 
SDS-PAGE (12%, discontinuous) electrophoresis (PAGE) was performed under reduced 
conditions using a glycine buffer system according to the instructions of the PAGE equipment 
manufacturer (Mini-PROTEAN®
 
 3 Cell and PROTEAN® II xi Cell, Bio-Rad Laboratories, 
Mississauga, ON).  
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4.2.4 Western blot of F4ac 
 
The isolated F4ac fimbriae were confirmed by Western Blot using Mini Trans-Blot 
Electrophoretic Transfer cell (Bio-Rad Laboratories, Mississauga, Ont., Canada). Briefly, the 
sample of isolated F4ac fimbriae was subjected to 1D SDS PAGE, transferred onto PVDF 
membrane (Bio-Rad Laboratories, Mississauga, Ont., Canada) using transfer buffer (25mM Tris, 
192 mM glycine, 20% v/v methanol, pH 8.3) under 100 V for 1 hour. The membrane was 
blocked in PBS containing 0.5 % Tween 20 (PBS-T) and 5% BSA for 1 h on shaker. Then the 
membrane was washed in PBS-T and incubated for 1.5 h with a 1:2000 dilution of rabbit anti-
F4ac polyclonal antibodies (Dr J.M. Fairbrother, Faculte de Medecine Veterinaire, Universite de 
Montreal, Saint-Hyacinthe, QC, Canada). After four washes for 5 min each with PBS-T, the 
membrane was incubated with a 1:10,000 dilution of ECL Plex CyDye conjugated secondary 
antibody (GE Healthcare Bio-Sciences, Uppsala, Sweden) for 1 hour on shaker while protected 
from light. The membrane was then washed four times for 5 min in PBS-T, protected from light, 
and rinsed three times in PBS. Detection of the secondary antibody signal was done by scanning 
the membrane with a fluorescent scanner (Typhoon Trio, GE Healthcare Bio-Sciences, Uppsala, 
Sweden). Finally, the anti-rabbit Cy5 signals were measured at 633 nm (670-nm band-pass filter, 
i.e. 670 BP 30) with photomultiplier’s (PMT) voltage of 500 V. 
 
4.2.5 Isolation of MFGM proteins 
 
MFGM proteins were isolated from porcine milk fat according to previously published 
methods with minor changes [144-145]. Porcine milk was obtained from healthy sows 21 days 
after farrowing (Prairie Swine Centre Inc., Saskatoon, SK, Canada) following subcutaneous 
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administration of 2 ml of oxytocin (MTC Pharmaceuticals, Cambridge, ON, Canada). The milk 
was expressed manually and kept at 4°C during transportation to the laboratory. The milk fat was 
obtained by centrifugation at 3600 x g for 30 min at 4°C. The skim milk was removed and the fat 
fraction was washed three times with PBS, followed by centrifugation at 1500 x g for 20 min at 
20ºC. The supernatant creamy layer was collected, resuspended in PBS, and subjected to 
intensive sonication (6 x 60 sec with cooling intervals on ice) to break and release MFGM 
proteins which were harvested by ultracentrifugation at 100,000 x g for 90 min at 4ºC. The pellet 
was resuspended in PBS and sonicated for 30 sec in order to prevent formation of protein 
aggregates. Concentration of proteins was measured by Quick Star Bradford protein assay and 
sample was filtered through 0.45 mm filters (Whatman 25mm GD/X Syringe filter, Clifton, New 
Jersey, USA) prior to affinity chromatography.  
 
4.2.6 Preparation of affinity matrix 
 
Approximately 50 mg of the purified F4ac fimbriae were coupled to 3 g of CnBr-activated 
Sepharose 4B (GE Healthcare Bio-Sciences, Uppsala, Sweden) according to the manufacturer’s 
instructions. A negative control column, with the omission of F4ac fimbriae, was similarly 
generated. 
 
4.2.7 Immuno-dot-blot 
 
An immuno-dot-blot technique was used to confirm the efficiency of coupling of F4ac 
fimbriae to CnBr-activated Sepharose 4B, according to a previously published method [11]. 
Briefly, 100 µl of coupling buffer (0.1 M NaHCO3, 0.5 M NaCl, pH 8.3) containing 50 µl of 
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CnBr-activated Sepharose 4B matrix (GE Healthcare Bio-Sciences, Uppsala, Sweden) with or 
without coupled F4ac fimbriae were loaded into wells of Bio-Dot SF microfiltration apparatus 
(Bio-Rad Laboratories). 100 µl of PBS containing 10µg purified F4ac fimbriae were loaded as 
positive control. The samples were filtered through PVDF membranes by negative pressure, and 
then the membranes were subjected to the same Western blot technique that was used for 
confirmation of the isolated F4ac fimbriae. 
 
4.2.8 Affinity Chromatography 
 
Both the F4ac-CnBr-activated Sepharose 4B and negative control CnBr-activated Sepharose 
4B matrices were packed into chromatography columns (XK 16/20, GE Healthcare Bio-
Sciences, Uppsala, Sweden) which were then used to isolate F4ac-binding proteins from MFGM 
proteins by affinity chromatography using ÄKTA purifier 10 chromatography system (GE 
Healthcare Bio-Sciences, Uppsala, Sweden) controlled by Unicorn 5.11 software. The F4ac-
CnBr-activated Sepharose 4B column was equilibrated with 5 column volumes of TBS buffer 
(10 mM Tris, 150 mM NaCl, pH 7.2) and then approximately 35 mg of MFGM proteins diluted 
in 24 ml of PBS was loaded to the column, which was then washed with 10 column volumes of 
TBS. The first (low affinity) elution was performed with 5 column volumes of 1 M NaCl in 10 
mM Tris (pH 7.2) followed by 2 column volume of TBS, while the second (high affinity) elution 
was done using 5 column volumes of 0.1 M Glycine–HCl (pH 2.5). These two elution fractions 
were collected and pooled separately, dialyzed for 48 h at 40C against deionized H20, using 1-
kDa-cut-off cellulose dialysis membranes (Spectra/Por, Spectrum Laboratories, Inc., CA, USA), 
and then lyophilized in Freeze Dry System/Freezone 2.5 (Labconco Corp., MO, USA). The same 
procedure was repeated for the negative control CnBr-activated Sepharose 4B column. The 
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elution fractions were separated in 12% polyacrylamide gel using 1 D SDS-PAGE, visualized by 
Coomassie stain and identified by nanoLC-MS/MS. 
 
4.2.9 NanoLC-MS/MS identification of proteins 
 
F4ac-binding proteins isolated by affinity chromatography were submitted for nanoLC-
MS/MS identification to the 
Briefly, proteins were excised from Coomassie stained SDS-PAGE, placed in clean 
Eppendorf tubes and destained overnight in 30% acetonitrile in 100 mM ammonium bicarbonate. 
The destained gel bands were reduced with DTT, alkylated with iodoacetamide and digestion 
overnight with sequencing grade trypsin (Promega, Madison, WI, USA) using standard 
laboratory protocols.  The resulting digests were analyzed by nanoLC-MS/MS with data 
dependent acquisition using a NanoAquity UPLC system (Waters, Milford, MA, USA) coupled 
to a LTQ XL linear ion trap mass spectrometer (ThermoFisher Scientific, San Jose, CA, USA). 
The samples were injected onto a 300 µm i.d. × 5 mm C18 PepMap100
Institute for Biological Sciences, National Research Council, 
Ottawa, ON.  
TM trap (Thermo Fisher 
Scientific - Dionex, Sunnyvale, CA, USA), and separated on a 10 cm x 100 µm i.d. C18 column 
(Waters, 1.7 µm BEH130C18) at ~400 nL/minute, using a 30 minute gradient:  1-45% solution B 
(100% ACN/0.1% formic acid) in 19 minutes, 45-85% B over 2 minutes, 85-1% B in 1 minute, 
hold at 1% for 8 minutes. The peptide MS/MS spectra were searched against the NCBInr 
mammalian database using the MASCOTTM search engine (Matrix Science, UK) for protein 
identification. The search parameters were: full tryptic cleavage, ≤1 missed cleavage, ≤1.5 Da for 
precursor ion, ≤1.2 Da for the fragment ions, oxidation (Met) and carbamidomethyl (Cys) as 
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variable modifications. For proteins with significance scores of 60 or less, all peptide MS/MS 
spectra were verified manually. 
 
4.3 Results 
 
F4ac fimbriae were isolated from bacterial culture, subjected to SDS PAGE, visualized by 
Coomassie stain and confirmed by Western blot (Figure 4-1). Purified F4ac fimbriae were 
coupled to CnBr-Sepharose affinity matrix (Figure 4-2) which was used for preparation of the 
affinity columns for the isolation of F4ac-binding proteins from porcine MFGM proteins. 
Affinity chromatography was performed with CnBr-activated Sepharose 4B (Figure 4-3) as 
negative control column and F4ac-fimbriae-CnBr-activated Sepharose 4B column (Figure 4-4) as 
experimental column. Elution fractions obtained in affinity chromatography were separated by 
1D SDS-PAGE and stained with Coomassie blue G-250 (Figure 4-5). MFGM proteins bound to 
F4ac-fimbriae coupled to activated Sepharose (positive column) were eluted by low (1M NaCl) 
and high (0.1M Glycine-HCl pH 2.5) affinity elutions, separated by 1D SDS-PAGE, visualized 
by Coomassie stain and identified by nanoLC-MS/MS as xanthine dehydrogenase, acyl-CoA 
synthetase 3, lactotransferrin, butyrophilin, adipophilin, lactadherin, and fatty acid binding 
protein (Table 4.1). The same procedure was repeated with the negative affinity column 
(containing only activated Sepharose), but the elutions contained only trace amounts of proteins, 
and they were not taken for further analysis. 
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4.4 Discussion 
 
Xanthine dehydrogenase, acyl-CoA synthetase 3, butyrophilin, adipophilin, lactadherin, and 
fatty acid binding protein were demonstrated to have binding affinity for purified F4ac fimbriae 
by affinity chromatography. These results are consistent with the previous study that investigated 
MFGM proteins interacting with F4ac fimbriae using overlay Western blot [11, 117].   
The experiment with an affinity chromatography technique revealed very similar results to 
those generated by overlay Western blot. More specifically, acyl-CoA synthetase 3, butyrophilin, 
adipophilin, lactadherin, and fatty acid binding protein were confirmed to bind to F4ac fimbriae 
by both techniques. However, the experimental conditions used in affinity chromatography and 
overlay Western blot experiments differed significantly. In the overlay Western blot technique 
MFGM proteins were subjected to reducing SDS-PAGE treatment that included effects of a 
reducing agent, i.e. dithiothreitol (DTT) and a denaturing detergent, i.e. sodium dodecyl sulphate 
(SDS) and a high concentration of urea. It is known that SDS denatures native proteins from 
their tertiary and secondary protein structure to their primary structure, i.e. individual 
polypeptides. Furthermore, DTT reduces all disulfide linkages, which destroys tertiary protein 
folding and breaks quaternary protein structure, i.e. oligomeric subunits [146]. On the other 
hand, experimental conditions of affinity chromatography should not have affected secondary, 
tertiary or quaternary structures of MFGM proteins; therefore, it is assumed that they were 
preserved at the moment of interaction with F4ac fimbriae. The similar results generated by two 
different experiments (i.e. affinity chromatography and overlay Western blot) suggest these two 
possible explanations. First is that primary structures of MFGM proteins are mainly responsible 
for interaction with F4ac fimbriae.  Another possibility is that binding affinity originates from a 
mechanism based on lectin-carbohydrate interaction. Evidence that such a possibility might be 
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correct is the example of human lactadherin, which demonstrated ability to inhibit binding of 
human rotavirus to target cells and prevent consequent diarrhea in infants.  Removal of the 
terminal sialic acid from the carbohydrate moiety of this glycoprotein eliminated its inhibitory 
ability, which suggested that glycan residues were responsible for binding to rotavirus [115]. In 
addition to that, it was demonstrated that porcine lactadherin exposed to periodate oxidation 
treatment abolished its ability to decrease binding of F4ac positive E. coli to intestinal villi ex 
vivo [11]. The periodate oxidation was used to test if interaction between lactadherin and F4ac 
fimbriae was mediated by a carbohydrate-lectin reaction. However, if this kind of procedure is 
not optimized, it could potentially alter not just the structure of carbohydrates, but also the 
protein portion of glycoproteins, and introduce potential false results. For example, partial or 
complete inactivation of the antibody can occur under the periodate oxidation, particularly if the 
easily oxidizable amino acids, such as cysteine, cystine, methionine, tryptophan, are present in 
the antigen binding site [147]. However, if glycan moieties are responsible for affinity of MFGM 
proteins for F4ac, their potential identification and characterization may be used for the purposes 
of development of a new strategy for the prevention of PWD. At the present time, only data for 
posttranslational modification of bovine lactadherin are available in the literature. Bovine 
lactadherin contains both N- and O- linked glycans. Compositional analysis and mass 
spectrometry suggested that N-linked glycans comprise of two oligosaccharide structures, e.g. 
typical high-mannose containing sequence (Manα1→6 (Manα1→3) Manβ1→4GlcNAcβ1-
→4GlcNAc) and GalNAcβ1→4GlcNAc [10]. The O-linked glycan of bovine lactadherin 
appeared to have a similar composition. However, study with lectins suggested that O- and N-
linked glycans associated with bovine lactadherin changes significantly their glycosylation 
profile during early lactation, which complicates comparison between individual samples [10]. 
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Interestingly, data from monosaccharide blocking studies indicated that terminal N-
acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc) and galactose (Gal) may play a 
central role in the interaction of the F4 adhesin with brush border receptors [148]. On the other 
hand, glycosylation modifications of porcine LAD and other MFGM proteins remain entirely 
unknown. We suggest that future efforts have to be directed to the identification and 
characterization of porcine LAD glycan portions. Bovine BTN has three potential N-linked 
glycosylation sites containing Galβ1→4GlcNAc, GalNAcβ1→4GlcNAc and high-mannose 
(Manα1→2Manα1→3-Manα1→6 and Galβ1→4GlcNAcβ1→2Manα1→3) structures. BTN is 
not known to contain O-linked glycans [10]. It is not confirmed that bovine ADPH, FABP and 
acyl-CoA synthetase 3 are glycosylated, but posttranslational modifications in these proteins 
have not been extensively studied so far [10]. This also applies to the same proteins from porcine 
MFGM, and it should be taken into consideration as an objective of future research 
investigations. Particularly, since all these proteins demonstrated interaction with F4ac fimbriae, 
the experimental approaches that aim to determine the mechanism of this binding, should be 
prioritized.  
Xanthine dehydrogenase was eluted by both low and high affinity elution buffers from the 
column containing F4ac-fimbriae coupled to CnBr-activated Sepharose 4B, but no interaction 
with F4ac was demonstrated with overlay Western blot. The reason for this discrepancy was not 
determined; however, the following is the most likely explanation. A protein complex formed by 
disulfide bonds among butyrophilin, adipophilin and xanthine dehydrogenase was described 
previously in MFGM [10]. Accordingly, it is possible that the entire complex was bound to F4ac 
fimbriae coupled to CnBr-activated Sepharose 4B, and subsequently eluted from it. Following 
reduced 1D SDS PAGE separation of the eluted proteins, xanthine dehydrogenase was also 
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present among F4ac-binding proteins. Since out of this protein complex only butyrophilin and 
adipophilin interacted with F4ac fimbriae in overlay Western blot, we suspect that the 
identification by affinity chromatography of xanthine dehydrogenase as an F4ac-binding protein 
was a false positive result. 
On the other hand the identification of lactotransferrin, or lactoferrin, in low pH eluate was an 
unexpected finding. This soluble protein is commonly found in secretory fluids, such as milk, 
saliva, tears, etc. [149]. In our opinion, there are two possible explanations for this finding. First 
is that we are dealing with a completely different protein from the one present in fluids, i.e. 
membrane bound lactoferrin, described so far only in human MFGM [150-151]. The second 
explanation is possible contamination of isolated MFGM proteins with skim milk proteins, i.e. 
lactoferrin, which may occur particularly during the washing of milk fat in the isolation 
procedure. However, the absence of other more abundant F4ac-binding proteins of skim milk 
(i.e. β casein) in both affinity chromatography eluates indicates that contamination is unlikely. 
Nevertheless, F4ac-binding ability of lactoferrin has never been demonstrated before and 
requires more clarification in the future.  
In conclusion, butyrophilin, adipophilin, lactadherin, acyl-CoA synthetase 3 and fatty acid 
binding protein 3 in porcine MFGM can bind to F4ac fimbriae in vitro. It is possible that these 
proteins serve as receptor analogues for F4ac fimbriae and may prevent attachment of E. coli to 
intestinal epithelium. 
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Figure 4-1 Identification of F4ac fimbriae. F4ac fimbriae isolated from enterotoxigenic E. coli, 
subjected to SDS-PAGE, visualized by Coomassie stain and detected by Western blotting using 
primary rabbit anti-F4-polyclonal antibodies and secondary anti-rabbit Cy5 antibodies (Lane 1 - 
Molecular Weight Markers; Lane 2 and 4 - Bovine serum albumin as negative control; Lane 3 
and 5 - isolated F4ac-fimbriae) 
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Figure 4-2 Immuno-dot-blot. 1) Isolated and purified F4ac fimbriae as positive control, 2) F4ac 
fimbriae coupled to CnBr-activated Sepharose 4B affinity matrix, and 3) CnBr-activated 
Sepharose 4B without F4ac fimbriae used as negative control affinity matrix tested with primary 
rabbit anti-F4-polyclonal antibodies and secondary anti-rabbit Cy5 antibodies 
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Figure 4-3 Affinity Chromatography with negative control column (CnBr-activated 
Sepharose 4B). 35 mg of MFGM proteins in 24 ml of PBS were applied to the column, washed 
for 10 column volumes and eluted with two different elution buffers. There were only minor 
elution peaks during both elutions, which were considered to be non-specific presumably due to 
changes in the buffers as observed also at the same time lag during the wash between two 
elutions. 
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Figure 4-4 Affinity Chromatography isolation of F4ac-binding proteins from MFGM 
proteins using a column containing F4ac fimbriae covalently bound to CnBr-activated 
Sepharose 4B. 35 mg of MFGM proteins in 24 ml of PBS were applied to the column, washed 
for 10 column volumes and eluted with two different elution buffers. Prominent elution peaks 
were observed in both elutions. 
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Figure 4-5 MFGM proteins eluted from positive affinity column (containing F4ac-fimbriae 
coupled to activated Sepharose), separated by one dimensional SDS-PAGE, stained by 
Coomassie Blue G-250 stain. Lane 1 – Low affinity elution with 1 M NaCl ; Lane 2 – High 
affinity elution (low pH  2.5); MFGM proteins identified by nanoLC-MS/MS: a) xanthine 
dehydrogenase, b) acyl-CoA synthetase, c) butyrophilin, d) adipophilin, e) lactadherin, f) fatty 
acid binding protein and g) lactotransferrin 
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Table 4.1 NanoLC-MS/MS identification of F4ac-binding MFGM proteins isolated by low (1M 
NaCl) and high (pH 2.5) affinity elutions.  
 
  Low affinity elution  
(1M NaCl) 
High affinity elution 
(pH 2.5) 
Protein IDs  Mass 
(Da)
Score
1 
Unique 
Peptides
2 Score
3 
Unique 
Peptides
2 
Xanthine 
dehydrogenase 
3 
146706 609 24 459 18 
Acyl-CoA 
synthetase 3 
80245 1235 33 694 2 
Lactotransferrin 77562 ------ ------ 1554 31 
Butyrophilin subfamily 
1 member A1-like 
59100 1038 26 908 25 
Adipophilin 50180 1951 33 2310 39 
Lactadherin 47819 956 21 830 22 
Fatty acid binding 
  
13219 415 8 370 5 
 
 1 - Calculated molecular weight of protein  
2 - The protein identification score obtained by the MASCOTTM
3 - Number of matched peptides 
 (Matrix Science, UK) 
search in NCBInr mammalian database (significance threshold p<0.05) 
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The previous study in our research laboratory [11, 117] demonstrated that several porcine 
MFGM proteins interacted with F4ac fimbriae in vitro and these findings were further confirmed 
by affinity chromatography (Chapter 4). Moreover, lactadherin, a major MFGM protein, was 
reported to inhibit the F4ac positive ETEC attachment to porcine intestinal villi ex vivo [11]. 
Accordingly, we hypothesized that the other F4ac-fimbrial binding proteins isolated from 
porcine MFGM inhibit the attachment of ETEC to enterocytes.   However, testing of this 
hypothesis proved to be very challenging in the beginning due to the lack of effective techniques 
for purification of selected proteins from MFGM. The phase separation technique with Triton X-
114 and size exclusion chromatography did not generate desired results. Finally, electro-elution 
was employed and individual proteins were isolated. To test the inhibitory effects of isolated 
MFGM proteins against ETEC attachment, competitive ELISA with an intestinal cell line or 
primary enterocytes was developed and used instead of a bacterial attachment assay using 
intestinal villi ex vivo. 
Prior to these experiments, attempts were made to determine the strength of binding of 
individual MFGM proteins to F4ac fimbriae by Surface Plasmon Resonance (SPR) technique. 
SPR is an optical detection technique, which detects refractive index changes in close proximity 
to a planar metal (gold) surface. When the analytes (e.g. MFGM protein)  bind to ligand 
molecules (e.g. F4ac fimbriae) immobilized on the surface, a change in the interfacial refractive 
index is detected and quantified by the instrument as a SPR signal, expressed in resonance units, 
RU (RU is equivalent to one picogram per square millimetre of sensor surface) [152]. Those 
proteins that would show a strong signal by SPR, i.e. affinity for F4 fimbriae, were planned to be 
tested for their inhibition effect on F4 positive ETEC attachment.  
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Two SPR experiments were attempted on the Biocore X system (GE Healthcare Life-
Sciences, Uppsala, Sweden) using different sensor chips.  The first experiment used a CM5 
sensor chip (GE Healthcare Life-Sciences, Uppsala, Sweden) with 100nm thick 
carboxymethylated dextran covalently attached to a gold surface. Immobilization of F4ac 
fimbriae (100 µg/ml in 10mM acetate buffer pH 5.0) was performed using an amine coupling 
procedure according to the manufacturer’s instructions. However, several attempts failed to 
immobilize sufficient amounts of purified F4ac on the surface of the sensor chip to reach the 
appropriate RU values (minimum 5000) for detection. Therefore in the second SPR experiment a 
streptavidin modified sensor chip, SAHC 1000M (Xantec Bioanalytics GmbH, Duesseldorf, 
Germany) and biotinylated F4ac fimbriae were used. The SAHC sensor chip is coated with 
bioinert polycarboxylate hydrogel matrix with streptavidin and allows immobilization of 
biotinylated ligands through a specific biotin-streptavidin interaction. Although this strategy 
seemed initially promising, SPR signal values obtained in the experimental setting never 
exceeded 2000 RU, which was not enough to detect significant differences in binding affinity 
between the positive and negative controls, therefore, the SPR experiments were terminated. 
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5 EVALUATION OF INHIBITION OF F4AC+ESCHERICHIA COLI ATTACHMENT 
WITH XANTHINE DEHYDROGENASE, BUTYROPHILIN, LACTADHERIN AND 
FATTY ACID BINDING PROTEIN 
 
This chapter will be submitted for publication to the Veterinary Microbiology as the following 
manuscript: 
Predrag Novakovic *, Chandrashekhar Charavaryamath *
(* equal contribution) 
, Betty Lockerbie, Radhey S. Kaushik, 
Matthew E. Loewen, Beverly A. Kidney, Igor Moshynskyy, Chris Stuart, Elemir Simko  
 
5.1 Introduction 
 
Post-weaning diarrhea (PWD) due to F4ac-positive enterotoxigenic Escherichia coli (ETEC) 
is an important cause of morbidity and mortality in weaned piglets [5]. Currently, PWD is 
controlled by various management strategies, use of antibiotics as feed supplements and/or 
immunization with vaccines containing fimbrial antigens. However, none of these control 
measures can completely eliminate PWD from modern swine production. In addition, continuous 
use of sub-therapeutic doses of antibiotics as feed supplements potentially leads to the 
emergence of genes encoding antimicrobial resistance in porcine microflora. These antimicrobial 
resistant genes may be incorporated by animal and human pathogens, potentially causing serious 
public health problems. Hence, there is a great demand to find alternative strategies for 
prevention and control of porcine post-weaning diarrhea (PWD). Many domestic animal species 
including pigs are born hypogammaglobulinemic and rely on sow’s milk for the immune 
protection.  Vaccination of sows efficiently protects piglets against ETEC infection only during 
nursing period. However, after weaning, ingestion of antibodies and other potentially protective 
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substances from sow’s milk is terminated, and piglets become highly susceptible to ETEC 
infection. Since the immune system of neonatal piglets is relatively naïve, the current vaccination 
strategies at that age are not sufficiently effective for protection against PWD [21]. In addition to 
immunoglobulins, porcine milk also contains a variety of non-immunoglobulin substances that 
can also interfere with ETEC attachment to enterocytes.  
Atroshi et al., reported that porcine MFGM can act as a target for binding of F4 positive E. 
coli [8]. Furthermore, it was demonstrated that porcine milk MFGM have the potential to inhibit 
binding of F4 fimbriae to porcine intestinal brush borders [9]. Recent studies revealed that 
certain proteins of porcine MFGM, such as lactadherin, butyrophilin, adipophilin, acyl-CoA 
synthetase and fatty acid binding protein have binding affinity for F4ac fimbriae of ETEC [11, 
117, 153].  
The purpose of this study was to isolate the previously identified F4ac-binding proteins from 
porcine MFGM and to determine if they can inhibit attachment of F4ac-fimbriae or F4ac positive 
E. coli to primary porcine enterocytes or IPEC-J2 cell line using competitive ELISA assay.  
 
5.2 Material and Methods 
 
5.2.1 IPEC-J2 cell line and culture conditions 
 
The IPEC-J2 [undifferentiated porcine intestinal epithelial cell line derived from porcine 
jejunum, a kind gift from Dr. Pradip Maitii (Nutratechglobal, Winnipeg, MB, Canada)] cells 
were seeded on cell culture flask (T75cm2, Corning, NY, USA) as described previously [154]. 
Briefly, IPEC-J2 cells were cultured and maintained in Dulbecco’s Modified Eagle Medium 
 52 
 
(DMEM)-Hank F12 (Gibco, Invitrogen Corporation, Grand Island, NY, USA) supplemented 
with 5% fetal calf serum (FCS, Atlanta Biologicals, Lawrenceville, GA, USA), penicillin (100 
IU/ml), streptomycin (100 μg/ml) (Invitrogen Corporation, Grand Island, NY, USA), and 5 
ng/ml of epidermal growth factor (Sigma Chemical Co., St. Louis, MD, USA). IPEC-J2 cells 
were maintained in a humidified incubator in an atmosphere of 5% CO2 and 95% air at 37o C. 
After 4 to 5 days of culturing, the confluent cell monolayer was briefly rinsed with 1x PBS pH 
7.4 (Gibco, Invitrogen Corporation, Grand Island, NY, USA) to remove all traces of serum. Five 
hundred microliters of 0.25 % Trypsin-EDTA solution (Gibco, Invitrogen Corporation, Grand 
Island, NY, USA) was added to the flask and incubated at 37oC.  Cells were observed under an 
inverted microscope and incubation was continued with trypsin-EDTA until the cell monolayer 
was completely dispersed (usually within 7 to 10 min). The detached cells were collected and 
centrifuged at 200 × g for 5 min, resuspended in ice cold phosphate-buffered saline (PBS) (1.6 
mM NaH2PO4, 9.4 mM Na2HPO4, 154 mM NaCl, pH 7.4) to a density of 2 x 106cells/ml before 
being used for the ELISA test. The continuous culture of the IPEC-J2 cells was maintained by 
seeding culture flasks at 1:4 or 1:5 ratios at each passage into T75cm2
 
 flasks.  
5.2.2 Pig enterocyte isolation 
 
The animal use protocol was reviewed and approved by the Animal Research Ethics Board 
(AREB) at the University of Saskatchewan and followed the principles established by the 
Canadian Council on Animal Care [155-156]. 
The isolation of fresh enterocytes was done by using a distended intestinal sac method as 
described previously [157]. Briefly, a six to eight day old piglet from Prairie Swine Center was 
euthanized with a halothane overdose (MTC Pharmaceuticals, Cambridge, ON, Canada) and 
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subsequent exsanguination. An 80-cm segment of jejunum was dissected, and rinsed with a pre-
incubation buffer [PBS with 0.2 mM phenylmethylsulfonyl fluoride (PMSF) and 0.5 mM 
dithiothreitol]. The caudal end was then clamped, and the segment was filled with isolation 
buffer (PBS with 1.5 mM EDTA, 0.2 mM PMSF, and 0.5 mM dithiothreitol) until fully 
distended. The cranial end was then clamped, and the distended jejunal segment was placed in 
pre-warmed saline in a 2 l beaker, kept on a shaking water bath at 37 o C. After 20 minutes of 
incubation  [158], contents of the segment including isolated enterocytes were collected into a 
conical tube and centrifuged  (400 x g for 3 min at 4oC). The cell pellet obtained after 
centrifugation was resuspended in ice cold PBS and this washing step was repeated 4 times. 
Finally, the enterocytes were resuspended in ice cold PBS to a density of 2 x 106 
 
cells/ml before 
using in an ELISA test. 
5.2.3 F4ac-positive Escherichia coli  
 
F4ac-positive Escherichia coli (reference strain P97-2554B, O149:K91:F4ac) isolated from 
the intestine of a pig with diarrhea at the faculty of Veterinary Medicine, University of Montreal, 
Saint-Hyacinthe, QC was kindly provided by Dr. Musangu Ngeleka, Prairie Diagnostic Services, 
Inc., Saskatoon, SK.  
 
 
5.2.4 Culture and use of F4ac-positive Escherichia coli 
 
An overnight growth of bacterium in tryptic soy broth (TSB) was mixed in sterile glycerol to 
a final concentration of 15% glycerol and stored at – 20 o C for future use. A loop full of glycerol 
 54 
 
stock culture was spread on a tryptic soy agar (TSA) plate with 5% sheep blood and incubated at 
37 o C overnight. Next day, a single colony was inoculated into 30 ml of TSB and incubated at 
37 o C with 150 rpm shaking over night.  The following day, the bacterial suspension was 
centrifuged (3000 x g, for 30 minutes at 25 o C) and the pellet was resuspended in carbonate 
buffer (100 mM NaCO3,
 
 pH 8.2). Using a spectrophotometer (NanoDrop 2000C, Thermofisher 
Scientific, Wilmington, DE, USA), OD of the bacterial suspension was adjusted to 0.7 (A550 
nm) against carbonate buffer as the blank value. 
5.2.5 Isolation and identification F4ac fimbriae 
 
F4ac fimbriae were isolated and purified according to a previously published method [143], 
the only modification being the introduction of filtration of solubilized F4ac fimbriae through 
0.20µm pore size filters (Nylon Membrane 0.2µm 47 mm PK/100, Millipore Corporation, MA, 
USA) before each step of precipitation at pH 4 during the purification process to prevent 
aggregation [153]. The concentration of isolated fimbriae was determined with Quick Star 
Bradford protein assay (Bio-Rad Laboratories, Mississauga, Ont., Canada), the purity  by 
Sodium Dodecyl Sulphate (SDS) Polyacrylamide Gel Electrophoresis (PAGE) separation and 
Coomassie staining and the identity by Western Blot technique  using rabbit anti-F4ac polyclonal 
antibodies (Dr J.M. Fairbrother, Faculte de Medecine Veterinaire, Universite de Montreal, Saint-
Hyacinthe, QB, Canada) as previously described [153]. The isolated F4ac fimbriae was stored at 
-20o
 
C in the PBS. 
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5.2.6 Isolation of xanthine dehydrogenase, butyrophilin, lactadherin and fatty acid 
binding protein 
 
MFGM proteins were isolated from porcine milk fat according to previously published 
methods [144-145] with minor changes described previously [153].  
Isolation of the four individual MFGM proteins of interest, namely, xanthine dehydrogenase 
(XDH), butyrophilin (BTN), lactadherin (LAD) and fatty acid binding protein (FABP) was done 
by electro-elution technique. Briefly, MFGM proteins were loaded in multiple lanes (100 
µg/well) and separated in 12% polyacrylamide gel by SDS PAGE using a large electrophoretic 
apparatus (Protean II xi Cell, Bio-Rad Laboratories, Mississauga, Ontario, Canada) under 
constant current of 24 mA for 5 hours. After separation, the reference lane was cut off and the 
separated proteins were visualized by Coomassie staining as previously described [159].The 
Coomassie-stained reference lane was lined up with the rest of the unstained gel to cut the 
regions of unstained proteins corresponding to individual separated and Coomassie-stained 
proteins in the reference lane.  Unstained gel regions containing individual MFGM proteins were 
sliced in 1-2 cm segments and loaded into an electro-elution system (Elutrap, Whatman, Dassel, 
Germany). After 8 hours of elution under 200 V in Tris-glycine buffer (25mM Tris, pH 8.3; 
192mM glycine; 0.1% Sodium Dodecyl Sulphate), eluted individual proteins were collected. The 
remaining SDS was removed from isolated proteins by dialysis (72 hours, with changes of 
deionized water every 4 hours, at 4o C) using cellulose dialysis tubing with 8 kDa cut-off 
(Spectra/Por, Spectrum Laboratories, Inc., CA, USA). Finally, purity of the individual proteins 
eluted from the 12% acrylamide gel was analyzed by Coomassie staining after SDS-PAGE 
separation, and the concentration was determined with Quick Star Bradford protein assay (Bio-
Rad Laboratories, Mississauga, ON, Canada). 
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5.2.7 Microscopic examination of adherence of F4ac-positive E. coli to IPEC-J2 and pig 
enterocytes 
 
IPEC-J2 cells or freshly isolated enterocytes (2 x 106 cells/ml, 100 µL/slide) were spread on 
microscopic glass slides, allowed to dry and stored at – 80 o
 
 C. Prior to use, the slides were 
allowed to thaw at room temperature and bacterial suspension (OD 0.7 at 550 nm) prepared in 
PBS containing 1% D-Mannose was added to the cells on the slide (200 µL/slide). Slides were 
kept gently shaking at room temperature for 1 hour, washed with PBS, dried, stained with Diff-
quick and cover slip mounted.  Entire area of slide was examined for bacterial attachment to the 
cells. 
5.2.8 Coating of microtiter plates with IPEC-J2 and pig enterocytes 
 
Immobilization of IPEC-J2 cells and fresh pig enterocytes was done as previously published 
[160]. Briefly, 100 μ1 of 1 M lysine solution (in distilled water) was added to each well of 96-
well, flat-bottomed polystyrene microtiter  plates (Gibco BRL, Canadian Life Technologies, 
Burlington, ON, Canada) and incubated for at least 10 minutes (up to 2 hours) at room 
temperature. After three washes with distilled water, 100 μ1 of a 1.25% glutaraldehyde solution 
(in distilled water) was added to each well. The plates were incubated for exactly 5 minutes and 
then they were washed 2 times with distilled water to activate the plates. PBS (100 μ1) was 
immediately added to each well, followed by 50 μl of cell suspension (2x 106 cells/ml, IPEC-J2 
or freshly isolated pig enterocytes). The optimal numbers of cells for competitive ELISA were 
determined by checkerboard titration in direct ELISA, testing various numbers of cells with 
various numbers of biotinylated F4-positive E. coli (see Appendix, Figure 8-2). The cells were 
gently mixed and allowed to settle for 10 minutes at room temperature. The plates were then 
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centrifuged for 10 minutes at 650 x g. The supernatant (100 μl) was aspirated with caution, so as 
not to disrupt the cell monolayer. The plates were then dried overnight at 37°C and stored at 
room temperature until used (not longer than 10 days).  
 
5.2.9 Biotinylation of F4ac-positive E. coli and F4ac fimbriae 
 
F4ac-positive Escherichia coli was cultured and bacterial suspension with optical density of 
0.7 at 550 nm in carbonate buffer as described above.  12.5 μ1 of reconstituted NHS-PEO4 
Biotin in distilled water (EZ-Link NHS-PEO-Biotinylation kit, Pierce Biotechnology, Rockfor, 
IL, USA) was added to 1 ml of the bacterial suspension, mixed and incubated for 2 hours at room 
temperature.  The bacteria were then washed 3 times with PBS (3000 x g, 10 minutes at room 
temperature) and finally resuspended in PBS with 1% (wt/vol) D-mannose (Sigma Chemical Co., 
St. Louis, MD, USA) to the original volume (5 ml) just before use in the ELISA test. The 
optimal numbers of bacteria (2 x 108
Biotinylation of F4ac fimbriae was done according to the manufacturer instructions for 
biotinylation of proteins (EZ-Link NHS-PEO-Biotinylation kit, Pierce Biotechnology, Rockfor, 
IL, USA). 
/ml of biotinylated F4ac-positive E. coli) for competitive 
ELISA were determined by checkerboard titration in direct ELISA, testing various numbers of 
biotinylated F4-positive E. coli with various numbers of porcine enterocytes (see Appendix, 
Figure 8-1). 
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5.2.10 Competitive ELISA for quantification of inhibition of adherence of F4ac-positive  
E. coli  
 
The competitive ELISA test for quantification of inhibition of F4ac-positive E. coli adherence 
to IPEC-J2 cells with isolated MFGM proteins was done as previously published [160]  with few 
modifications. The unoccupied plastic spaces in a 96-well microtiter plate containing 
immobilized IPEC-J2 was blocked by adding 300 μl/well of a 5% solution of BSA in PBS. The 
plate was incubated for 3 hours at 37°C and washed 3 times in PBS (300 μl/well). Then, 1 ml of 
2 x 108 biotinylated F4ac-positive E. coli in 1% PBS-D-mannose buffer had been pre-incubated 
with isolated xanthine  dehydrogenase (5, 25 or 125 μg); butyrophilin (5, 25 or 125 μg); 
lactadherin (5, 25 or 125 μg), or fatty acid binding protein (5, 25 or 125 μg). Rabbit anti-F4ac 
polyclonal antibody was used as positive control (5, 25, or 125 μg of polyclonal serum proteins) 
(Dr J.M. Fairbrother, Faculte de Medecine Veterinaire, Universite de Montreal, Saint-Hyacinthe, 
QB, Canada), and rabbit anti-F6 polyclonal antibody (125 μg) (Dr J.M. Fairbrother, Faculte de 
Medecine Veterinaire, Universite de Montreal, Saint-Hyacinthe, QB, Canada) and lactalbumin 
(125 μg) (Gibco BRL, Canadian Life Technologies, Burlington, ON, Canada) as negative 
controls. In order to determine nonspecific binding, additional controls were also included, such 
as wells with only cells (immobilized IPEC-J2 or fresh enterocytes) without biotinylated F4ac-
positive E. coli, and wells with PBS only without cells or biotinylated F4ac-positive E. coli. 
After 1 hour of incubation of biotinylated F4ac-positive E. coli with test reagents at room 
temperature with gentle shaking, 50 μl was added to each well of the microtiter plate for ELISA. 
The plate was incubated for 40 minutes at 37oC, and subsequently washed 3 times with PBS. 
Then 100 μl of PBS was added into each well and the plate was heat-fixed for 10 minutes at 60-
65°C. After that PBS was removed and horseradish peroxidase streptavidin conjugate (100 
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μl/well, 1:7000 dilution in PBS) (Vector Laboratories, Inc., Burlingame, CA, USA) was added to 
each well and incubated for 30 minutes at 37°C. The plate was washed 3 times with PBS, and 
100 μl of TMB microwell peroxidase substrate system (KPL, Gaithersburg, MD, USA) was 
added to each well. The color was allowed to develop in the dark for 15 to 30 minutes and then 
stop solution (2N H2SO4
The competitive ELISA test for quantification of inhibition of F4ac-positive E. coli adherence 
to pig enterocytes with isolated MFGM proteins was done as described for IPEC-J2 cells, with 
the exception that freshly isolated enterocytes were used to coat microtiter plates. 
, 100 μl/well) was added. ELISA optical density (OD) was measured at 
450nm within 30 minutes with Spectra Max 340 PC Spectrophotometer operated by SoftMax 
Pro software (Molecular Devices Corporation, Sunnyvale, CA, USA). The OD of test wells was 
plotted after deducting the average OD of wells treated with PBS only in order to account for 
non-specific background color development. 
 
5.2.11 Competitive ELISA for quantification of inhibition of F4ac fimbriae attachment 
 
The competitive ELISA for quantification of inhibition of F4ac fimbriae attachment to IPEC-
J2 with MFGM proteins was performed similarly as described for F4ac-positive E.coli. This test 
was used to determine whether isolated MFGM protein mediated inhibition of F4ac-positive E. 
coli adherence to IPEC-J2 cells in vitro is because of the specific interaction between MFGM 
protein and F4ac fimbriae. The ability of biotinylated F4ac fimbriae to attach to IPEC-J2 cells 
and optimal concentration for competitive ELISA test were determined by direct ELISA, testing 
various concentrations of biotinylated F4ac fimbriae on IPEC-J2 coated microtiter plates (see 
Appendix, Figure 8-3).  The concentration of 0.5 μg/ml of purified biotinylated F4ac fimbriae 
was determined as optimal and used in the competitive ELISA test as described for competitive 
 60 
 
ELISA for quantification of inhibition of adherence of F4ac positive E. coli to IPEC-J2 cells with 
MFGM proteins. Briefly, 0.5 μg/ml (molar concentration, 18.52 nM) of biotinylated F4ac 
fimbriae was incubated with 5 μg/ml (66.67 nM), 25 μg/ml (333.33 nM), or 125 μg/ml (1.67 
μM) of  xanthine  dehydrogenase; 5 μg/ml (151.51 nM), 25 μg/ml (757.57 nM), or 125 μg/ml 
(3.79 μM) of butyrophilin; 5 μg/ml (212.77 nM), 25 μg/ml (1.06 μM), or 125 μg/ml (5.32 μM) of 
lactadherin; and 5 μg/ml (769.23 nM), 25 μg/ml (3.85 μM), or 125 μg/ml (19.23 μM) of fatty 
acid binding protein for 1 hour at room temperature. The negative controls and other conditions 
of the test were the same as described above. 
 
5.2.12 Statistical analysis 
 
The data were analyzed for statistical significance (P < 0.05) by ANOVA with Tukey’s 
multiple comparisons test (post-hoc test) using Prism 5 for Windows, version 5.04 (GraphPad 
Software, Inc., La Jolla, CA, USA). 
 
5.3 Results 
 
5.3.1 Adherence of F4ac-positive E. coli to IPEC-J2 cell and pig enterocytes 
 
In order to assess the ability of each MFGM protein of interest to inhibit F4ac-positive E. coli 
adherence to porcine intestine, we employed an already established cellular system (IPEC-J2 cell 
line) [154] and confirmed that F4ac-positive E. coli adheres to both IPEC-J2 cells and pig 
enterocytes in a slide adherence assay (Figure 5-1).   
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5.3.2 Isolation of F4ac fimbriae from F4ac-positive E. coli 
 
We isolated F4ac fimbriae from bacterial culture, analyzed its purity by SDS-PAGE 
separation and Coomassie staining and confirmed its identity by Western blot (Figure 5-2). 
 
 
5.3.3 Isolation of MFGM proteins 
 
We isolated xanthine dehydrogenase, butyrophilin, lactadherin, and fatty acid binding protein 
by electro-elution. To confirm purity of individual proteins we separated those by SDS-PAGE, 
and visualized by Coomassie blue stain (Figure 5-3). 
 
5.3.4 Quantification of inhibitory effect of MFGM proteins on attachment of F4ac-
positive E. coli to the IPEC-J2 cells 
 
We performed three different experiments to analyze the inhibitory effect of MFGM proteins 
against F4ac-positive E. coli adherence by competitive ELISA. The first experiment consisted of 
Competitive ELISA test for quantification of inhibition of adherence of F4ac-positive E. coli to 
IPEC-J2 cells with various concentrations (5, 25 or 125 μg) of MFGM proteins in comparison to 
positive (rabbit anti-F4ac polyclonal antibody) and negative controls (rabbit anti-F6 polyclonal 
antibody and lactalbumin) and demonstrated that lactadherin, butyrophilin, and fatty acid binding 
protein inhibit adherence of F4ac-positive E. coli to the IPEC-J2 cells (Figure 5-4). 
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5.3.5 Quantification of inhibitory effect of MFGM proteins on attachment of F4ac-
positive E. coli to the pig enterocytes 
 
In the second experiment we tested biological relevance of our in vitro system IPEC-J2 by 
repeating Competitive ELISA test with freshly isolated pig enterocytes and obtained very similar 
results (Figure 5-5). 
 
5.3.6 Quantification of inhibitory effect of MFGM proteins on attachment of F4ac 
fimbriae to the IPEC-J2 cells 
 
Finally, in order to confirm that inhibition of F4ac-positive E. coli adherence to IPEC-J2 cell 
line in vitro is because of the specific interaction between MFGM protein and F4ac fimbriae, we 
designed the Competitive ELISA test for quantification of inhibition of F4ac fimbriae attachment 
to IPEC-J2 cells and confirmed that inhibition of attachment is mediated by interaction between 
individual MFGM proteins and F4ac fimbriae (Figure 5-6). Based on comparative inhibitory 
molar concentrations of MFGM proteins and F4ac, it appeared that 5 molecules of LAD, 50 
molecules of BTN, and 200 molecules of FABP were needed to inhibit attachment of one 
molecule of F4ac fimbriae to IPEC-J2 cells.  
 
5.4 Discussion 
 
In the current study, we demonstrated that butyrophilin, lactadherin and fatty acid binding 
protein interfere with attachment of F4ac-positive E. coli to the IPEC-J2 cells or porcine 
enterocytes. The inhibitory effect exhibited by these MFGM proteins appears to be in a dose-
dependent manner and due to a specific interaction with F4ac fimbriae.  
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It has long been known that porcine milk fat globule surrounded by milk fat globule 
membrane (MFGM) binds to F4-positive E. coli [8]. We demonstrated previously by two 
independent techniques (overlay Western blot and affinity chromatography) that acyl-CoA 
synthetase 3, butyrophilin, adipophilin, lactadherin, and fatty acid binding protein 3  have 
binding affinity for  F4ac fimbriae in vitro [153].  In this study we confirmed not only that they 
interact with F4ac fimbriae, but they also exhibit inhibitory effects against binding of F4ac-
positive E. coli to enterocytes and non-transformed porcine jejunal epithelial cell line (IPEC-J2) 
in vitro. 
Lactadherin is a 46 kDa peripheral glycoprotein, and a major protein on MFGM. Lactadherin 
has an N-terminal epidermal growth factor (EGF)-like domain, which mediates binding to αvβ5 
integrin [128]. Multiple functions of lactadherin have been reported so far. Lactadherin is 
involved in cellular adhesion, neovascularization and clearance of apoptotic cells [119, 129, 
161]. Human lactadherin is associated with protection of human infants against rotaviral 
infection [115]. Porcine lactadherin was reported to have high affinity for F4ac fimbriae [117] 
[11] and able to prevent binding of F4ac positive E. coli to intestinal villi ex vivo [11]. Consistent 
with the previous report [11], lactadherin was found in this study to inhibit the attachment of 
F4ac positive E. coli to primary enterocytes and a jejunal cell line and attachment of purified 
F4ac fimbriae to a jejunal cell line. Compared to butyrophilin and fatty acid binding protein, 
lactadherin appears to be the most potent inhibitor of E. coli attachment to enterocytes.  Based on 
comparative inhibitory molar concentrations of lactadherin and F4ac, it seems that a minimum of 
5 molecules of lactadherin is needed to inhibit binding of 1 molecule of F4ac fimbria to a jejunal 
cell line. 
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Butyrophilin is the most abundant protein of MFGM [162]. It is a type I membrane 
glycoprotein and belongs to the immunoglobulin superfamily [118]. Milk fat secretion is 
mediated by a complex of butyrophilin, xanthine dehydrogenase and adipophilin [119]. The 
biological importance of butyrophilin has not been defined so far. We previously reported that it 
has a binding affinity to F4ac fimbriae in vitro, and here we confirmed that it inhibits F4ac 
positive E. coli attachment to enterocytes by interaction with F4ac fimbriae. 
Fatty acid binding protein of MFGM is a 13 kDa protein [10]. Initially it was known as 
mammary-derived growth inhibitor, because it inhibited growth of mammary carcinoma cells 
[136]. Fatty acid binding protein in MFGM consists of a mixture of heart type and adipocyte 
type fatty acid binding protein [163]. Bovine mammary fatty acid binding protein does not 
appear to be glycosylated. The function of milk fatty acid binding protein is not yet clear [10]. 
Previous studies demonstrated that fatty acid binding protein from porcine milk interacts with 
F4ac fimbriae of ETEC in vitro [11, 117]. In this study we demonstrated that fatty acid binding 
protein inhibits F4ac positive E. coli attachment to enterocytes and IPEC-J2 cell line.  
Xanthine dehydrogenase is present in many mammalian tissues, but it is a major constituent 
of the MFGM. Xanthine dehydrogenase is a complex enzyme comprising of two identical 147 
kDa subunits [131], which catalyzes the oxidation of purines to uric acid by addition of oxygen 
from H2O [10]. Xanthine dehydrogenase has been suspected to play an important role during the 
secretion of milk fat, facilitated by formation of a complex with butyrophilin and adipophilin 
[164]. Reactive oxygen species generated by xanthine dehydrogenase may also act as 
antibacterial components.  In our previous study, xanthine dehydrogenase was isolated by F4ac-
affinity chromatography together with other F4ac-fimbrial binding proteins, but its interaction 
with F4ac fimbriae was not detected with overlay Western blot [117, 153]; accordingly, we 
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suspected that the identification by affinity chromatography of xanthine dehydrogenase as a 
F4ac-binding protein was a false positive result. This was further confirmed in the current study 
by evidence that xanthine dehydrogenase did not inhibit attachment of F4ac positive E. coli to 
enterocytes or IPEC-J2 cell line nor purified F4ac fimbriae to IPEC-J2 cell line. 
The inhibition of attachment of 0.5 µg/ml of F4ac fimbriae to IPEC-J2 cells with various 
concentrations of candidate MFGM proteins was tested in Competitive ELISA. Results 
suggested that only 5, 25 or 125 µg/ml of lactadherin and 25 or 125 µg/ml of butyrophilin and 
fatty acid binding protein were significant competitors. When molar concentrations of MFGM 
proteins were compared with F4ac fimbriae molarity, it appeared that 5 molecules of lactadherin, 
50 molecules of butyrophilin, and 200 molecules of fatty acid binding protein were needed to 
inhibit attachment of one molecule of F4ac fimbria to IPEC-J2 cells.  
In conclusion, lactadherin, butyrophilin and fatty acid binding protein reduce attachment of 
F4ac-positive E. coli to primary enterocytes and jejunal cell line (IPEC-J2) in vitro. The 
mechanism of this inhibition was not determined, but previous studies on lactadherin 
demonstrated that the glycosylated portion of lactadherin played an important inhibitory role and 
served as receptor analogues for F4ac fimbriae [11]. Future studies will be needed to determine 
the inhibitory importance of glycan portions of butyrophilin and fatty acid binding protein, and 
the potential importance of MFGM proteins in prevention of enteric colibacillosis in vivo.  
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Figure 5-1 Adherence of F4ac-positive E. coli to IPEC-J2 cells and pig enterocytes. 
Microscopic examination shows in vitro adhesion of F4ac-positive E. coli to IPEC-J2 cells (A) 
and freshly isolated pig enterocytes (B) stained with Diff-quick stain (100x oil immersion 
objective). 
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Figure 5-2 Isolation of F4ac fimbriae from F4ac-positive E. coli. F4ac fimbriae isolated from 
F4ac-positive E. coli, subjected to (A) 12% SDS-PAGE, and visualized by Coomassie Blue 
staining (B) and detected by Western blotting using primary rabbit anti-F4-polyclonal antibodies 
and secondary anti-rabbit Cy5 antibodies (Lane 1 – (A) Molecular weight markers; (B) ECL Flex 
Rainbow Molecular Weight Markers; Lane 2 - Bovine serum albumin as negative control; Lane 
3- isolated F4ac fimbriae). 
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Figure 5-3 Isolation of MFGM proteins. Milk Fat Globule Membrane (MFGM) proteins 
isolated from porcine milk, subjected to 12% SDS-PAGE separation, and visualized by 
Coomassie Blue staining (Lane 1 – MGFM proteins; Lane 3 – Electroeluted fatty acid binding 
protein; Lane 4 – Electroeluted lactadherin; Lane 5 – Electroeluted butyrophilin; Lane 6 – 
Electroeluted xanthine dehydrogenase) 
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Figure 5-4 Quantification of inhibitory effect of MFGM proteins against attachment of 
F4ac-positive E. coli to the IPEC-J2 cells. Inhibition of F4ac-positive E. coli adherence to 
IPEC-J2 cells with various concentrations (5, 25 or 125 μg) of xanthine dehydrogenase (XD), 
butyrophilin (BTN), lactadherin (LAD), fatty acid binding protein (FAB); positive (rabbit anti-
F4ac polyclonal antibody) and negative (rabbit anti-F6 polyclonal antibody and lactalbumin 
[LA]) controls. Only treatments marked with asterisk (*) are significantly different (P < 0.05) 
from both untreated (IPEC-J2 + F4+ E. coli) and negative controls (LA and anti-F6 Ab). 
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Figure 5-5 Quantification of inhibitory effect of MFGM proteins against attachment of 
F4ac-positive E. coli to the pig enterocytes. Inhibition of F4ac+E.coli adherence to freshly 
isolated pig enterocytes with various concentrations (5, 25 or 125 μg) of XD, BTN, LAD, FAB; 
positive (rabbit anti-F4ac polyclonal antibody) and negative (rabbit anti-F6 polyclonal antibody 
and LA) controls. Only treatments marked with star (*) are significantly different (P < 0.05) 
from both untreated (indicate as in the previous figure) and negative controls (indicate as in the 
previous figure). 
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Figure 5-6 Quantification of inhibitory effect of MFGM proteins against attachment of 
F4ac fimbriae to the IPEC-J2 cells. Inhibition of F4ac fimbriae attachment to IPEC-J2 cells 
with various concentrations (5, 25 or 125 μg/ml) of XD, BTN, LAD, FAB; positive (rabbit anti-
F4ac polyclonal antibody) and negative (rabbit anti-F6 polyclonal antibody and LA) controls. 
Treatments marked with asterisk (*) are significantly different (P < 0.05) from untreated (IPEC-
J2 + F4ac fimbriae) control and treatments marked with (#) are significantly different (P<0.05) 
from negative controls (LA and anti-F6 Ab). 
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6 GENERAL DISCUSSION 
 
The aims of the studies presented in this thesis were to isolate and characterize F4ac binding 
proteins from porcine MFGM, and evaluate their potential inhibitory effect on F4ac positive E. 
coli attachment in vitro. The experiment with affinity chromatography purification of F4ac 
binding proteins from MFGM presented in Chapter 4, revealed that xanthine dehydrogenase, 
acyl-CoA synthetase 3, butyrophilin, adipophilin, lactadherin, and fatty acid binding protein are 
binding to F4ac fimbriae coupled to activated Sepharose. Results generated by a competitive 
ELISA experiment presented in Chapter 5, demonstrated that butyrophilin, lactadherin and fatty 
acid binding protein inhibited adherence of F4ac E. coli to intestinal epithelial cells in vitro, but 
xanthine dehydrogenase did not. These results are consistent with the previous two studies 
conducted by our research group [11, 117].  
The affinity chromatography experiment for isolation and purification of F4ac binding 
proteins from MFGM was adapted from previously published studies [11, 143]. The intention 
was to create in vitro experimental conditions biologically relevant to those required for 
pathogenesis of F4ac positive ETEC associated with post-weaning diarrhea. More specifically, 
our aim was to simulate the condition, where F4ac fimbriae mediated attachment enables E. coli 
bacteria to withstand the forces of intestinal peristalsis, by using a fast protein liquid 
chromatography (FPLC) system with controlled peristaltic flow. Of course, this approach did not 
take into consideration many other important factors present in the porcine intestine, which 
consequently might impact the biological relevance and interpretation of generated data. 
Nevertheless, affinity chromatography intended to offer independent verification of the results 
obtained in a previous study [117] that tested the interaction between MFGM proteins and F4ac 
fimbriae under complex chemical conditions associated with two-dimensional SDS PAGE. 
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Availability of simple and relatively rapid procedures for purification of sufficient amounts of 
F4ac fimbriae (50mg per 10ml column) [143] and MFGM proteins [144-145] made these 
experiments feasible. The inclusion of negative (control) CnBr-activated Sepharose 4B column 
together with an experimental column containing F4ac fimbriae covalently coupled to CnBr-
activated Sepharose 4B had the purpose of comparing and subsequently excluding MFGM 
proteins that bind to Sepharose media, but not to F4ac fimbriae. Extensive wash (10 column 
volumes) was used to remove MFGM proteins that bound nonspecifically to the affinity matrix 
and/or ligand. Low (1M NaCl) and high (pH=2.5) affinity elutions were used to isolate proteins 
bound to F4ac fimbriae coupled to activated Sepharose.    
The results demonstrated significant differences in amounts of MFGM proteins eluted from 
the negative control column and the experimental column with F4ac fimbriae. Fractions of 
proteins eluted from the negative control by 1M NaCl and low pH elutions were almost 
undetectable (<0. 1µg/ml per affinity chromatography run) as determined with Quick Star 
Bradford protein assay (Bio-Rad Laboratories, Mississauga, ON). Due to very low amounts of 
proteins they were not submitted for nanoLC-MS/MS identification. On the other hand, 
considerable amounts of proteins were eluted from the experimental column with F4ac fimbriae 
by both types of elutions (1mg/ml per affinity chromatography run). F4ac-fimbrial binding 
MFGM proteins eluted by 1M NaCl and low pH conditions were separated by 1D SDS PAGE, 
stained with Commassie (Chapter 4, Figure 4-5), excised, and identified by nanoLC-MS/MS as 
xanthine dehydrogenase, acyl-CoA synthetase 3, butyrophilin, adipophilin, lactadherin, fatty acid 
binding protein and lactotransferrin.  
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Affinity chromatography results were consistent with those obtained previously by  Overlay 
Western blot technique [117]. Even though the experimental conditions used in affinity 
chromatography and overlay Western blot experiments differed markedly, both studies identified 
the following proteins that had binding affinity for F4ac fimbriae: acyl-CoA synthetase 3, 
butyrophilin, adipophilin, lactadherin, and fatty acid binding protein. In the overlay Western blot 
technique MFGM proteins were exposed to chemical treatment that included reducing agent, 
DTT and denaturing detergent, SDS. These reagents have ability to destroy quaternary, tertiary  
and secondary protein structure and reduce it to its primary structure [146]. On the other hand, 
experimental conditions of affinity chromatography did not change quaternary, tertiary or 
secondary structures of proteins from MFGM; hence, the proteins were in their native form from 
the moment of their reaction with F4ac fimbriae.  
There are two possible explanations for these findings. The first explanation is that primary 
structures of MFGM proteins are playing an important role in interaction with F4ac fimbriae.  
Another explanation suggests that this mechanism is strictly based on lectin-carbohydrate 
interaction. Evidence that strongly supports this possibility is the example of human lactadherin. 
This glycoprotein inhibits binding of human rotavirus to their target cells and consequently 
prevents infant diarrhea.  When the terminal sialic acid from the carbohydrate moiety of this 
glycoprotein was removed, the inhibitory activity for rotavirus was reduced. This strongly 
suggested that glycan residues were responsible for binding to rotavirus [115]. Additionally, 
when porcine lactadherin was treated with metaperiodate, it lost its ability to reduce binding of 
F4ac positive E. coli to intestinal villi ex vivo [11]. Periodate oxidation was used to confirm that 
the interaction between lactadherin and F4ac fimbriae is carbohydrate-lectin based. However, 
this procedure can potentially be damaging not just to carbohydrates, but also to proteins, and it 
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may introduce potential false results. Partial or complete inactivation of the antibodies may occur 
under the periodate oxidation, particularly if the easily oxidizable amino acids are essential for 
antigen binding [147]. Nevertheless, if glycan moieties are confirmed as binding sites on MFGM 
proteins for F4ac fimbriae, their characterization will become vital for development of a new 
strategy for prevention of PWD.  
At the present time, only bovine lactadherin is known to contain both N- and O- linked 
glycans. N-linked glycans are comprised of two oligosaccharide structures, e.g. typical high-
mannose containing (Manα1 → 6 (Manα1 → 3) Manβ1 → 4GlcNAcβ1 → 4GlcNAc) and 
GalNAcβ1 → 4GlcNAc sequence [10]. Interestingly,  monosaccharide blocking studies indicated 
that terminal N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc) and galactose 
(Gal) may play a central role in the interaction of the F4 fimbriae with intestinal brush border 
receptors [148]. In contrast, glycosylation of porcine LAD and other porcine MFGM proteins 
remain completely unknown. 
Xanthine dehydrogenase and lactotransferrin were a new finding in the affinity 
chromatography study. Given that the affinity chromatography experiment was based on use of 
native MFGM as the analyte, it was not clear whether this interaction was genuine or not. 
Therefore, we planned to purify this protein from MFGM and test its capacity to bind F4ac in 
vitro. The isolation of lactotransferrin, much better known as lactoferrin, from low pH eluate was 
completely unanticipated, because this soluble protein is frequently associated with secretory 
fluids, particularly skim milk. We believed that there are two possible explanations for this 
finding. The first explanation was that this lactoferrin is a regular part of MFGM, or so called 
membrane bound lactoferrin, a different entity from the one present in fluids, described so far 
only for human MFGM [150-151]. The second explanation is possible contamination of isolated 
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MFGM proteins with skim milk proteins, i.e. lactoferrin, which may have occurred during the 
washing of milk fat in the isolation procedure. However, the absence of other more abundant 
F4ac-binding proteins of skim milk (i.e. β casein) in both affinity chromatography eluates 
indicates that contamination is unlikely.  
The second goal of this study was very challenging at the beginning because of several 
difficulties. Isolation of each individual protein from MFGM was a very complex task, due to 
lack of available techniques for purification. A few purification strategies were explored (e.g. 
phase separation with Triton X-114, etc.), but finally the decision was made to use the electro-
elution technique to isolate individual MFGM proteins that were previously separated by SDS 
PAGE. Another challenge of this study was the establishment of the competitive inhibition assay 
to test individual MFGM proteins for their ability to inhibit attachment of F4ac positive E. coli. 
The in vitro villous adhesion assay has been the most commonly used and described assay for 
this type of studies in the literature. However, after taking into account all advantages and 
disadvantages associated with this assay, it was decided to employ enzyme-linked 
immunosorbent assay (ELISA) for this study. In general, ELISA systems are highly versatile, 
rapid, sensitive, and quantitative techniques for estimation of attachment of microorganism in 
vitro [165]. A previously described ELISA system [160] has been modified for the quantification 
of attachment of F4ac positive E. coli and F4ac fimbriae. The innovation, compared to the old 
system, which used porcine enterocytes, was an introduction of a new cellular system, IPEC-J2 
cell line. IPEC-J2 is a non-transformed columnar epithelial cell line isolated from neonatal piglet 
mid-jejunum by Helen Berschneider at the University of North Carolina in 1989 [166]. Initially, 
this cell line was used as a model of the porcine small intestine in a study of the pathogenesis of 
porcine proliferative enteropathy [167]. After that, interest for IPEC-J2 has begun to grow 
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particularly in studies that investigate epithelial innate immune responses to microorganisms 
[168]. Salmonella enterica and Escherichia coli were most commonly used with IPEC-J2. IPEC-
J2 cells can be invaded by S. enterica serovars, S. typhimurium and S. choleraesuis [169]. A 
particularly important fact for this study was that the IPEC-J2 cell line was widely used in 
adherence studies of pathogenic strains of E. coli [168]. It was confirmed that enteropathogenic 
E. coli induces attaching and effacing lesions on IPEC-J2 cells [169]. Several studies have 
demonstrated that F4 positive ETEC adhere to IPEC-J2 cells [154, 170]. Even more, it was 
confirmed that purified F4 fimbriae were capable of binding to IPEC-J2 cells [154, 170]. On the 
other hand, there are indications that IPEC-J2 cells do not express the F18 specific receptor, and 
F18 positive ETEC strains do not bind to these cells [154, 171]. Porcine ETEC strains were 
shown to bind to porcine gut epithelial IPEC-J2 better than to human-derived intestinal INT-407 
cells, which confirms also the host specificity of this cell line [154]. Based on all these features 
of the IPEC-J2 cell line, it was decided to use them for the competitive inhibition study. It is 
believed that they significantly improved reproducibility of results and prevented possible 
variations due to the phenotypic or individual differences between pigs in this study. Results of 
competitive ELISA presented in Chapter 5 of this thesis confirmed that lactadherin isolated from 
porcine MFGM inhibits adherence of F4ac positive E. coli to porcine enterocytes in vitro more 
efficiently than any other porcine MFGM protein tested. This finding strongly supports and 
validates results obtained in previous studies [11, 117]. This study also demonstrated the 
inhibition effects of butyrophilin and fatty-acid binding protein. Xanthine dehydrogenase did not 
demonstrate a significant inhibitory effect on adherence of F4ac positive E. coli in vitro, even 
though it was isolated as an F4 binding protein in the affinity chromatography experiment. This 
might be explained by the fact that, in the native MFGM, this protein is complexed with 
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butyrophilin, which was undoubtedly confirmed to interact with F4ac fimbriae. The competitive 
ELISA technique was found to be a fast, reliable and sensitive method for testing inhibitory 
effects of proteins against attachment of F4ac positive E. coli, and F4ac fimbriae to enterocytes. 
 
6.1 Conclusions/Future directions 
 
In conclusion, the studies presented in this thesis demonstrated that porcine MFGM is 
composed of several proteins that have binding affinity for F4ac fimbriae and that some of them 
have the ability to inhibit attachment of F4ac positive E. coli to porcine enterocytes in vitro. 
They are most likely not key factors of innate protection against ETEC in porcine milk, but in 
conjunction with other substances may contribute to the defense against infection.  
Future research work in this area has the potential to evolve into several different directions. 
One may be focused on investigation of mechanisms that are responsible for the inhibitory effect 
of MFGM proteins on F4ac positive E. coli attachment. For example, identification and 
characterization of glycan portions of porcine LAD and other F4-binding MFGM proteins may 
prove to be a very useful approach. Several experimental approaches could be employed for that 
purpose. Lectin binding studies could be used to identify either an oligosaccharide sequence of 
interest or the carbohydrate composition of these glycoproteins. Moreover, sequential enzyme 
digestion studies could also identify potential binding sites on the glycan moieties of LAD and 
other MFGM proteins of interest. For example, different glycoside hydrolases have the ability to 
remove specific terminal monosaccharide or oligosaccharide residues from glycoproteins, which 
could be later evaluated for their inhibitory activity against the bacterial attachment in a 
competitive inhibition assay. Subsequently, based on loss of the inhibitory effects associated 
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with carbohydrate hydrolysis, the structure of the functional carbohydrate moiety of the 
particular glycoprotein could be determined. 
Another direction for future research may be feasibility studies for the application of MFGM 
proteins in prevention of PWD in pigs. However, this would require clinical trials with an 
investigation of effects of these proteins on ETEC infection in vivo. Even if there were beneficial 
effects, the commercial feasibility of production of porcine MFGM proteins is highly unlikely. 
Alternative sources of MFGM proteins, such as those from bovine milk would have to be 
considered. Bovine MFGM proteins are found in significant quantities in buttermilk, a 
commercially available byproduct of industrial dairy production of butter [172]. However, both 
in vitro and in vivo studies are needed first to determine if bovine MFGM proteins have an 
inhibitory effect on F4 positive ETEC attachment. 
Considering all possible options, the best approach would be to discover specific carbohydrate 
receptor analogs that could be commercially produced and added as non-antibiotic feed additives 
for the prevention of porcine PWD.   
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8 APPENDIX 
 
 
The Competitive ELISA system, previously described by Ofek et al., 1986, was optimized, 
before it was used in this study (Chapter 5). In other words, the working concentration of each 
component of the test was assessed. More specifically, this assessment was done through the use 
of checkerboard titrations (CBTs). The process of CBTs involves the dilution of two reagents 
(i.e. porcine enterocytes and biotinylated F4ac-positive E. coli) against each other to examine the 
activities inherent at all the resulting combinations. In the first step, porcine enterocytes were 
attached to 96-well polystyrene microtiter plates as described in Chapter 5 in a series of two fold 
dilutions starting from row A to G.  Row H received diluent only (PBS). The second step of 
titration involved making a series of two fold dilutions of biotinylated F4ac-positive E. coli from 
column 1 to 11. Column 12 received only PBS. After incubation and washing, the color was 
developed as described in Chapter 5. The OD was measured at 450 nm and results were plotted 
as follows.   
 
 101 
 
 
Figure 8-1 OD values obtained relating different numbers of biotinylated F4ac-positive E. 
coli per well to different numbers of porcine enterocytes per well of microtiter plate. Curves 
show titration of biotinylated F4ac-positive E. coli at different dilutions of porcine enterocytes. 
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Figure 8-2 OD values obtained relating different numbers of porcine enterocytes per well to 
different numbers of biotinylated F4ac-positive E. coli per well of microtiter plates. Curves show 
titration of porcine enterocytes at different dilutions of biotinylated F4ac-positive E.coli per well 
of microtiter plate. 
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The results of CBTs test revealed that 1×107
When optimal number of 100,000 enterocytes per well for ELISA test was determined, this 
number of cells was used for assessment of optimal concentration of biotinylated F4ac fimbriae 
for Competitive ELISA test for quantification of inhibition of attachment of F4ac fimbriae to 
IPEC-J2 cell (Chapter 5). 100,000 IPEC-J2 cells were coated on the 96-well polystyrene 
microtiter plate and incubated with biotinylated F4ac fimbriae in a series of two fold dilutions 
starting from column 1 to 12. The same procedure for development of color and reading was 
repeated as in Chapter 5 and OD values were plotted as follows: 
 of biotinylated F4ac-positive E. coli per well and 
100,000 porcine enterocytes showed the best correlation of obtained OD values (curve that 
graphically presents almost linear fitting). Additionally, obtained OD values for this number of 
bacteria and enterocytes range between 1.5-1.7 OD units, which met the requirements for 
obtaining accurate result in ELISA test (Crowther, 2009). Finally these results were entirely in 
agreement with the conditions of ELISA test protocol previously described by Ofek et al., 1986. 
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Figure 8-3 OD values obtained relating different concentration of biotinylated F4ac fimbriae 
to optimal number of porcine intestinal epithelial cells (IPEC-J2). Curve shows graphically the 
plateau maximum value of about 2.5 OD units.  
 
The results demonstrated that concentrations of biotinylated F4ac fimbriae in a range between 
0.5-1 µg/ml obtained optimal OD values (1.5-1.7 OD units). Hence it was decided to use 0.5 
µg/ml of biotinylated F4ac for the purpose of this study (Chapter 5). 
 
 
